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ABSTRACT
The translocation of GLUT4 from intracellular stores to the plasma membrane in 
response to insulin results in the large insulin-mediated glucose uptake in fat and 
muscle tissue. Individuals with insulin resistance and type II diabetes are known to 
have a defect in this translocation mechanism. As such, a greater understanding of the 
molecular basis of GLUT4 translocation and recycling is essential in order to design 
therapies for these diseases.
In this study, we have used sucrose gradient analysis to examine the intracellular 
distribution of GLUT4. This method allowed for the intracellular GLUT4 to be 
separated into the two pools of GLUT4 containing vesicles. One of these is highly 
insulin responsive and corresponds to the specialised GLUT4 storage vesicles 
(GSVs), while the other corresponds to the less insulin responsive endosomal GLUT4 
vesicles. It is these specialised GSVs which are believed to allow the large (up to 20- 
fold) increase in plasma membrane levels of GLUT4, compared to only ~2-fold 
increase in levels of recycling proteins (such as the transferrin receptor) in response to 
insulin. The GSVs are small vesicles (~50nm) and exclude the transfen’in receptor 
(and other recycling proteins) found in endosomal vesicles.
Here we demonstrated that in response to insulin there is -50% decrease in levels of 
GLUT4 in GSVs compared to only a 10-20% decrease in levels of GLUT4 in 
endosomes. We also demonstrate that these sucrose gradients can be used to 
determine whether other proteins co-localise with GSVs or the endosomal pool.
I l l
The Seel/ MunclS (SM) protein munc 18c is known to interact with syntaxin4 (a t- 
SNARE present in insulin responsive cells), which is an interaction that appears to 
inhibit glucose transport by preventing GLUT4 vesicles from undergoing fusion with 
the plasma membrane. Here we investigated whether a mutated form of the neuronal 
SM isoform (munc 18a) is capable of functioning in a similar manner to immc 18c 
(from a sequence alignment of munc 18a and munc 18c we identified specific amino 
acids to mutate based on the known 3D structure of the munc 18a-syntaxinl 
interaction). If indeed the mutated protein is seen to exhibit binding characteristics 
similar to munc 18c, then it may be possible to establish the importance of the munc 
18c-syntaxin4 interaction on GLUT4 integration into the plasma membrane by 
making recombinant Adenoviral constructs of the munc 18 proteins, and expressing 
these in mammalian cells.
Having made the initial mutations, we demonstrate here that in vitro the mutant munc 
18 protein has inlierited the syntaxin4 binding capabilities of the wild-type munc 18c. 
However, we were not able to then get expression of each of the recombinant 
Adenoviral constructs in mammalian cells, and as such we were unable to establish 
the effect that these mutations would have upon GLUT4 fusion with the plasma 
membrane, and ultimately glucose transport.
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CHAPTER 1 INTRODUCTION
1,1 Glucose as an energy source
Glucose is a fundamental source of energy for all eukaiyotic cells. In humans, the 
main consumer of glucose under basal conditions is the brain, which accounts for as 
much as 80% of whole body consumption. The energy is provided by the breakdown 
of endogenous glycogen stores that am mainly in the liver. These energy stores are 
then replenished by glucose in the diet that, after being digested and absorbed across 
the gut wall, is distributed among various tissues of the body (reviewed in Shepherd 
& Kahn 1999),
The distribution of glucose is cairied out by a family of glucose transporters (called 
GLUTs), which function by moving sugar across the cell membrane. An important 
function of one specific glucose transporter is to respond to increased levels of 
glucose in the bloodstream by storing glucose in muscle and adipose tissue. This 
tightly controlled process prevents lai'ge fluctuations in blood glucose levels, which 
can be harmfiil (this will be discussed in further detail below).
1.2 Insulin action in fat and muscle
In 1980, it was established that, in rat adipocytes, insulin stimulates the movement of 
the specialised glucose transporter that is found in these cells horn an intracellular 
store to the plasma membrane (Suzuki & Kono 1980; Cushman & Wardzala 1980).
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The emergence of this glucose transporter at the cell surface meant that increased 
glucose transport (above the basal level) could then take place into these cells.
Insulin is secreted by the p-cells of the pancreas in response to high blood glucose 
levels. A specific glucose transporter (GLUT2) mediates entiy of glucose into these p- 
cells, and as such allows them to respond to an increased level of glucose in the 
bloodstream. An increased level of glucose within p-cells initiates a chain of events 
ultimately leading to the release of insulin from these cells, and into nearby blood 
vessels.
The effects of insulin are dependent on the presence of an insulin receptor, to which 
insulin binds, and this leads to a cascade of events indicating to the cell the presence 
of elevated blood glucose levels. In both adipose and muscle cells this signal results in 
the uptake of glucose into those cells, and as such blood glucose levels are restored to 
normal. In these cells the glucose is metabolised and either converted into glycogen 
(in muscle), or fatty acids (in adipose tissue).
It has since been determined that this specialised glucose transporter is GLUT4. A 
defect in the translocation of GLUT4 will result in a reduced uptake of glucose in 
response to insulin, and is thought to be the underlying cause of diseases such as 
diabetes mellitus.
1.3 Diabetes
Diabetes mellitus can be divided into two different types: insulin-dependent diabetes 
mellitus (IDDM) and non insulin-dependent diabetes mellitus (NIDDM), now called 
type I and II respectively. Type I diabetes often occurs in childhood, and is thought to
be genetically determined leading to the destruction of P-cells in the pancreas and 
hence to insulin deficiency. Type I can often be treated successfully by the 
administration of insulin. On the other hand, type II diabetes is often called “late onset 
diabetes” and is greatly influenced"by external factors such as diet and lifestyle. Both 
types of diabetes show a phenotype of hyperglycemia, but as mentioned before type I 
patients produce no insulin, whereas type II patients are often hyperinsulinaemic. 
Type II as well as obesity is characterised by insulin resistance. Studies on non- 
diabetic offspring of two diabetic patients deteimined that they have a 50% risk of 
becoming diabetic in later life, suggesting that type II is also genetically determined. 
This possibility increased greatly if the individuals were also obese, suggesting an 
environmental influence in the development of type II diabetes (reviewed in Kahn 
1994).
Insulin resistance precedes the development of type II diabetes. Patients that are 
diabetic have probably been insulin resistant for several years prior to the disease 
being diagnosed, usually only as the consequence of the appearance of side effects of 
the disease. These side effects are caused by the increased blood glucose levels over 
an extended period of time, and include (in extreme cases) blindness, kidney failure 
and cardiovascular disease. Often the decreased insulin sensitivity seen in patients 
leads to an increase in insulin production, which again could further reduce insulin 
sensitivity. On the other hand, in other patients, insulin secretion is severely impaired 
before the onset of diabetes. In such patients, insulin treatment is only sometimes 
effective due to the fact that the patients are insulin resistant. There is therefore a great 
demand for drugs which can alleviate this by increasing insulin sensitivity.
The prevalence of type TÏ diabetes is increasing at a large rate. In 1998, 143 million 
people worldwide suffered from the disease, and it is estimated that this could double 
in the next 20-30 years (Harris et al 1998). Therefore, there has been a significant 
level of research looking into finding the molecular basis for insulin resistance. Any 
defect in the insulin-signalling cascade or in GLUT4 translocation could lead to the 
development of insulin resistance. Studies making use of human tissue and rodent 
models of diabetes have determined that there is probably not just one point in the 
cascade of events that is defective. There could be an accumulation of different
defects, and there may be diffèrent reasons for the development of insulin resistance 4■|
in diffèrent patients. I;
It is now known that a defective glucose transport is the main reason for insulin /
resistance in type II patients (Bonadonna et al. 1993; Bonadonna et al. 1996; Kelley et
îal. 1996). These results suggest a defect in the translocation of GLUT4 to the plasma 
membrane, leading to a reduced number of transporters in the plasma membrane. In 
support of this, impaired GLUT4 translocation has been found in muscle of obese, 
insulin resistant and type II diabetic patients (Kelley et al. 1996; Garvey et al. 1998).
Muscle tissue accounts for the majority of post-prandial glucose uptake at about 70-
.80% compared to 5-20% in adipose tissue (as reviewed in Hunter & Garvey 1998). 4
' ,4'Down regulation of GLUT4 in those tissues could explain the decreased glucose 
transport in diabetic patients, and indeed in adipocytes GLUT4 levels are down by 
about 80-90% (Garvey et al. 1991). However, GLUT4 levels in muscle are unchanged 
(Garvey et al. 1992) and therefore GLUT4 depletion cannot be the only reason for 
insulin resistance in type II diabetes. This defect in muscle tissue could be due to
either a defect in the translocation mechanism of GLUT4, or due to mis-targeting of 
GLUT4 to an insulin insensitive location.
1.4 Insulin signalling
1.4.1 The insulin receptor
The insulin receptor is expressed ubiquitously and is composed of two a and two (3 
subunits (reviewed in Virkamaki et a l 1999; Elmendorf & Pessin 1999). These form 
a heteroteramer linked via disulphide bonds. The a subunits are extracellular and 
contain the insulin binding domain. The (3 subunits span the membrane but the 
majority of this polypeptide is located within the cytosol. This receptor belongs to the 
tyrosine kinase family of receptors, and the intracellular (3 subunits contain tyrosine 
kinase activity (reviewed in Kahn 1994; Virkamaki et a l 1999). Insulin binding to the 
a subunits results in a conformational change in the receptor that increases the 
intrinsic kinase activity and leads to the autophosphorylation of the receptor p 
subunits (reviewed in Kahn 1994). The tyrosine residues on the receptor that become 
phosphorylated in response to insulin binding, and are important for the activation of 
downstream signalling pathways, have been identified by mutagenesis (Holman & 
Kasuga 1997).
Recent studies have demonstrated the presence of two insulin signalling pathways 
leading to GLUT4 translocation. These will be summarised below.
1.4.2 The classic pathway of insulin signalling
The most important downstream targets for the insulin receptor in terms of glucose 
transport are the insulin receptor substrate (1RS) family of proteins. 1RS proteins have 
a similar overall structure, containing a N-terminal pleckstrin homology (PH) domain 
and a phosphotyr osine binding (PTB) domain, both of which are required for efficient 
tyrosine phosphorylation of 1RS by the insulin receptor (Virkamaki et al 1999).
These phosphotyrosine residues on 1RS proteins provide docking sites for proteins 
with Src homology 2 (SH2) domains. Many proteins contain such domains, and hence 
can bind 1RS proteins. However, the most important for glucose transport is 
Phosphatidylinositol 3-kinase (PI3-kinase) (Zhou et al 1997). PI3-kinases consist of 
two subunits, both of which have several isoforms. It is the regulatory subunit (p85) 
of PI3-kinase that recruits the catalytic subunit (pi 10) to the plasma membrane, where 
it catalyzes the phosphorylation of the 3’ position in the inositol ring of 
phosphoinositide (PI) lipids. Specifically PI3-kinase catalyses the formation of 
PI(3,4)P2 and PI(3,4,5) P3 (Fruman et a l 1998).
The phosphorylation of the 3’ position recruits and activates proteins containing PH 
domains, including 3’ phosphoinositide-dependent kinase-1 (PDK-1) and AKT 
(protein kinase B) (Rameh & Cantley 1999). In turn, PDK-1 phosphorylates and 
activates downstream effectors including PKB and the atypical protein kinase C (JX.
A variety of functional data has determined the importance of the PI3-kinase pathway 
in glucose transport. For example, experiments using the PI3-kinase inhibitors
wortmannin and LY294002 have shown that PI3-kinase is crucial for insulin- 
mediated glucose uptake (Okada et al. 1994; Cheatham el a l 1994; Clarke et al 
1994). The roles of PKB and the atypical protein kinase C, and their downstream 
targets are less well understood (see Figure 1.1 Signal 1).
1.4.3 An alternative pathway of insulin signalling -  Cbl/CAP complex
Cbl is the cellular homologue of the v-Cbl onco-protein. It is approximately 120kDa 
in size, predominantly cytosolic and contains many proline-rich motifs, with which it 
can bind SH3 domains on other proteins. It has been established that insulin can 
tyrosine phosphoiylate Cbl in 3T3-L1 adipocytes (Ribon & Saltiel 1997) and this can 
allow the binding of Cbl with several other proteins. In p cells Cbl was shown to bind 
to p85, and consequently it is believed that it may be important in PI3-kinase 
recruitment and activation in these cells (Kim et ai 1995). However in 3T3-L1 
adipocytes, this interaction between tyrosine phosphorylated Cbl and PI3-kinase was 
not seen (Ribon & Saltiel 1997).
It is now believed that Cbl can bind the insulin receptor via the Cbl associated protein 
(CAP). The interaction of CAP with Cbl is mediated by binding of the SH3 domains 
in CAP to the proline-rich motifs in Cbl, and is independent of insulin action. CAP 
also binds to the insulin receptor and insulin stimulation results in a time-dependent 
dissociation of the CAP-insulin receptor complex (Ribon et al 1998). The tyrosine 
phosphoiylation of Cbl is known to occur tlirough the insulin receptor in collaboration 
with CAP and the adaptor protein APS. When Cbl is phosphorylated, the CAP-Cbl— 
APS protein complex is recruited to the lipid raft microdomain, through association 
with the raft protein Rotillin (Baumann et a l 2000).
An interesting discoveiy is that the introduction of CAP lacking the SFI3 domains 
(CAPASH3) into 3T3-L1 adipocytes had no effect on PÏ3-kinase activity, but was 
found to inhibit insulin-mediated GLUT4 translocation by -50-60% (Baumann et al 
2000). This finding would suggest that insulin can generate a signal (tlirough the 
CAP-Cbl complex) leading to glucose transport, but is independent of PI3-kinase. 
Phosphotyrosine on Cbl was found to recruit a complex containing the associate with 
the adaptor protein Crkll and the guanine nucleotide exchange factor C3G into the 
lipid raft domain. The recruited C3G then causes the GTP/GDP exchange and 
activation of the TCIO GTPase (Watson et al 2001) (see Figure 1.1 Signal 2).
It has recently been suggested that a downstream target of this TCIO protein could be 
the exocyst complex, and that the TCI 0-exocyst complex is then responsible for 
targeting GLUT4-containing vesicles to appropriate plasma membrane fusion sites 
(Inoue et a l 2003; Kanzaki & Pessin 2003). The exocyst complex is responsible for 
tethering the exocytotic vesicles to the appropriate sites of the plasma membrane, and 
this will be discussed below.
A recent study has however provided evidence to counter the potential role of this 
alternate pathway in insulin stimulated glucose transport. By means of the 
administration of small interfering RNAs (siRNA) it has been possible to selectively 
deplete the intermediates of this pathway (notably CAP, Cbl and Crkll) and obseiwe 
the resulting effects. Results from this study showed that these intermediates can each 
be depleted in cultured adipocytes without compromising GLUT4 translocation by 
insulin. These results would indicate that these proteins are not required components
of insulin signaling to GLUT4 transporters (Mitra et al. 2004), and as such would 
question whether there are mdeed two separate signals leading to glucose transport.
Taken together, these results therefore suggest that insulin can potentially generate 
two independent signals leading to glucose transport, one dependent on and the other 
independent of PI3-kinase.
1.4.4 Insulin signalling in diabetes
Clearly defects in insulin signalling could lead to insulin resistance and diabetes (as 
reviewed in Virkamaki et al. 1999; Saltiel 2001). Although rodent models are 
valuable in studying insulin resistance, and have been used extensively, very few 
provide a real model of type II diabetes with the same phenotype as that found in 
human diabetes. Consequently, recent studies have focussed upon finding signalling 
defects in diabetic patients.
Signalling defects that cause insulin resistance ai'e rare, but some will be mentioned 
here. It has however been established that there are several aequired defects in insulin 
resistance. A down regulatiop of insulin receptor as well as decreased tyrosine kinase 
activity has been found in type II diabetics, but this can be restored through weight 
loss (Friedenberg et al. 1988). Decreased IRS-1 expression has also been identified in 
adipocytes of insulin resistant patients, although interestingly 1RS-2 was found to 
substitute for IRS-1 and the main insulin-stimulated PI3-kinase activity was now 
associated with 1RS-2 (Rondinone et al. 1997). However, in skeletal muscle no 
difference in IRS-1 expression was observed, but decreases in its tyrosine 
phosphorylation in response to insulin have been reported, together with a defect in
insulin-stimulated PI3-kinase activity in type II diabetic patients (Bjornholm et al 
1997). PKB activity and levels had originally been shown to be unaltered in diabetic 
patients. However, a recent study screening genomic DNA fi’om patients with severe 
insulin-resistance (for mutations in genes implicated in insulin signalling) has 
identified a mutation in PKB that promotes insulin resistance (George et al 2004).
Genetic defects in insulin signalling proteins, such as the insulin receptor, are very 
uncommon and only found in some syndromes such as leprechaunism and type A 
insulin resistance (reviewed in Hunter & Garvey 1998). There are several 
polymoiphisms occuiTing in IRS-1, which are increased in type II diabetic patients. 
These do not cause a large defect on IRS-1 function, but decreased PI3-kinase activity 
has been reported in some (Almind et a l 1996; Imai et al 1997). To date the only 
mutation discovered in PI3-kinase is present at the same frequency in diabetic and 
normal individuals, and it is therefore unlikely to be important in the development of 
insulin resistance and type II diabetes (as reviewed in Sheperd et al 1998; Virkamaki 
et al 1999).
1.5 Glucose Transport
Glucose is the major energy source for most mammalian cells, and in order to be used 
in the cytosol, it has to be transported across the plasma membrane.
There are two major types of glucose transporters: The sodium-dependent transporters 
use a Na"^  gradient to drive accumulation of glucose (as reviewed in Bell et al 1993),
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and will not be discussed further here, and the facilitative glucose transporters that 
move glucose down its chemical gradient (and do not use energy for this transport).
1.5.1 The family of glucose transporters
There are several isofoims of the facilitative glucose transporters. At present the 
family comprises thirteen members, which are separated into three subclasses based 
on sequence homology and structural similarity. They are products of distinct genes, 
exhibit tissue-specific expression, and are independently controlled. These facilitative 
glucose transporters are integral membrane proteins, and their structures will be 
discussed below.
GLUTl was the first to be isolated from red blood cells and is ubiquitously expressed. 
It is the major transporter at the blood-tissue barriers and provides cells with glucose 
even if extracellular levels are low. GLUTl is sometimes refeiTed to as the “house­
keeping” glucose transporter as it provides tissues with a constant low level supply of 
glucose (as reviewed in Gould & Scatter 1997).
GLUT2 is a bi-functional glucose/fructose transporter and is mainly expressed in the 
liver, the (3-cells of the pancreas and the small intestine, hi the liver it is important for 
both the import and export of glucose (depending on blood glucose levels), thereby 
ensuring the important role of the liver in whole body glucose homeostasis (as 
reviewed in Gould & Holman 1993; Gould & Scatter 1997).
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GLUTS is the neuronal glucose transporter, and is crucial for supplying the brain with 
glucose. The brain has a high glucose demand, and cannot use any other energy 
source. Consequently GLUTS has the lowest Km of all the transporters studied 
functionally to date (as reviewed by Bell et al. 1993).
GLUT4, the “insulin-sensitive glucose transporter” is the most intensively studied 
member of the family (as reviewed in Rea & James 1997). It is expressed in muscle, 
heart and fat tissue and undergoes insulin-mediated translocation from an intracellular 
store to the plasma membrane thereby ensuring the insulin responsiveness of those 
tissues. This results in glueose uptake into glucose storage tissues and subsequently 
glycogen is synthesised in muscle, and fatty acids and triglycerides are made in fat 
cells. This transporter is discussed in more detail below.
These four GLUTs comprise the class I glut transporters. GLUTs 5, 7, 9 and 11 
comprise class II transporters, and transport fructose. GLUTs 6, 8, 10, 12 and HMITl 
comprise class III transporters, and at present these are poorly defined (as reviewed in 
Joost and Thorens 2001).
1.5.2 Structure
Analysis of the hydropathy plots of the predicted amino acid sequences of the 
different isoforms has shown that these proteins adopt similar structures (Figure 1.2). 
These studies predict an integral membrane protein with twelve amphipathic helices 
spanning the membrane, and with both the N- and C-teiminus on the cytoplasmic 
side. There are large loops between helices 1 and 2 (extracellular) and 6 and 7 
(intracellular) (as reviewed in Gould & Holman 1993). The major features of this
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model have been experimentally confirmed (as reviewed in Gould & Seatter 1997) 
and it is believed that in order to allow glueose to traverse the membrane, five of the 
twelve helices form an aqueous pore through which transport may occur (as reviewed 
in Barrett et al 1999). Conformational studies using chimeras of the different glucose 
transporter isoforms have allocated specific functions to certain structure, sequences 
or even amino acids within these transporters. The substrate-binding site is known to 
be composed from different regions of the transporter. Binding of substrate to the 
exofacial site causes a conformational change re-orientating the sugar-binding site to 
the endofacial conformation and subsequent release of the substrate into the 
cytoplasm (as reviewed in Gould et a l 1997; Banett et al 1999).
1.6 GLUT4
1.6.1 The translocation hypothesis
:
In contrast to the other glucose transporter isoforms, which are located principally at 
the plasma membrane, 95% of GLUT4 (the “insulin-sensitive glucose transporter”) is 
located in intracellular vesicles and tubules (Slot et al 1991a; Slot et al 1991b).
When present, insulin causes the translocation of these vesicles to the cell surface, 
resulting in up to 20-fold increased levels of GLUT4 at the plasma membrane and 
therefore increased glueose transport (as reviewed in Rea & James 1997). The 
intracellular location of GLUT4, and the mechanism of its translocation will be 
discussed in detail below.
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1.6.2 Localisation by EM
Since it was discovered that GLUT4 is predominantly located intracellularly, much 
research has focussed into examining the nature of the GLUT4 containing 
compartment. Electron microscopy studies (using brown adipose tissue or rat cardiac 
muscle) determined GLUT4 to be localised to about 40% in tubulo-vesicular 
structures near the Golgi, some of this being TGN probably. A further 50% was found 
in tubulo-vesicular structures scattered throughout the cytoplasm (Slot et al. 1991a; 
Slot et al 1991b). GLUT4 localisation in tubulo-vesicular structures both near the 
TGN as well as throughout the cytoplasm has also been confirmed in skeletal muscle 
(Ploug et a l 1998). In order to determine whether GLUT4 is actually located within 
the TGN, and not just near it, experiments using rat atrial cardiomyocytes (a secretory 
cell type) were used. In these cells, a large proportion of GLUT4 (50-60%) was found 
in the secretory granules, which proves that GLUT4 traffics tluough the TGN during 
recycling (Slot el al 1997). However, GLUT4 vesicle purification studies argue 
against the TGN being the principal intracellular storage compartment in adipocytes 
(M artine/a/. 1994).
In brown adipose tissue, GLUT4 levels at the plasma membrane were observed to be 
around 1 % in the absence of insulin, confirming the theory that GLUT4 is excluded 
from the cell surface in the absence of insulin stimulation. The presence of insulin 
then resulted in a redistribution of GLUT4 from these intracellular structures to the 
plasma membrane by about 40 % (Slot et al 1991a; Slot et al 1991b). Another effect 
of insulin stimulation was an increased labelling of GLUT4 in clathrin lattices and 
early endosomes, implying that GLUT4 is endocytosed via clathiin- coated pits. This
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is a well-described mechanism for other membrane proteins (reviewed by Robinson et 
al 1996).
More recently, a method to isolate cytoplasmic sheets from rat adipocytes has allowed
a 3-D resolution of the intracellular GLUT4 compartments using electron microscopy
(Ramm et al 2000). In this study the majority of GLUT4 was found associated with 
.small vesicles (60%) whilst a smaller level of GLUT4 was associated with tubules 
(25%). Interestingly, insulin caused a reeruitment of GLUT4 mainly from the small 
vesicles, and translocation of GLUT4 is thought to occur via fusion of these vesicles 
with the plasma membrane, rather than sorting of GLUT4 out of the vesicles (Ramm 
et a l 2000).
Studies using Brefeldin A in 3T3-L1 adipocytes have provided indirect evidence in 
favour of the concept that GLUT4 is targeted to an intracellular insulin-responsive 
compartment that is distinct from the TGN and/or endosomes (Martin et al. 2000). 
Here, through the co-localisation of GLUT4 with a TGN/endosomal marker protein, it 
was shown that a significant proportion of GLUT4 recycles between the TGN & 
endosomes. However, disruption of this recycling pathway by Brefeldin A had no 
significant effect on the basal distribution of GLUT4; the insulin-dependent 
movement of GLUT4 to the plasma membrane; and the reformation of the insulin- 
responsive GLUT4 compartment (Martin et a l 2000).
Taken together these results provide evidence of GLUT4 in different intracellular 
compartments, and this will be discussed in further detail below.
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1.6.3 Multiple compartments
t
It is known that GLUT4 is pndocytosed via clathrin-coated pits (Slot et al 1991a; 
Robinson et al 1992), and recycles constantly between the plasma membrane and 
intracellular sites both in the presence and absence of insulin (Robinson et a l 1992; 
Yang & Holman 1993). GLUT4 partially co-localises with a number of other proteins 
such as GLUTl (Calderhead et al 1990; Robinson & James 1992), the mannose-6- 
phosphate receptor (M6PR) (Kandror & Pilch 1996) and the transferrin receptor (TfR) 
(Tanner & Lienhard 1989) in endosomes. These proteins also undergo insulin 
responsive translocation to the cell surface in 3T3-L1 adipocytes (Tanner & Lienhard 
1987; Tanner & Lienhaid 1989; Calderhead et al 1990; Kandror & Pilch 1996; 
Kandror & Pilch 1998; Subtil et al 2000). This increase however is only about 2-fold 
compared to the -  20-fold increase of GLUT4 (Tanner & Lienhard 1987; Calderhead 
et al 1990; Piper et al 1991). This implies that although GLUT4 is partly present in 
the same compartments as these proteins, a significant fraction is localised to a 
compartment that is distinct from endosomes, and which is highly responsive to 
insulin (Yang & Holman 1993).
The idea that GLUT4 populates at least two different intracellular compartments 
(endosomes and GSVs) has been suggested from data using a variety of methods. 
From a kinetic viewpoint, the behaviour of GLUT4 recycling kinetics can only be 
explained by the presence of at least two intracellular GLUT4 pools (Holman et al
1994). In this study, the merpbrane irnpermeant bismannose photolabel ATB-BMPA 
was used to tag GLUT4 af the plasma membrane after insulin treatment, and the 
subsequent re-distribution of this tagged GLUT4 was examined. The behaviour of
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tracer-tagged GLUT4 was then fitted into different models for GLUT4 recycling 
(Figure 1.3). The 3-pool model with two intacellular pools, one early endosome pool 
(Tee) and one tubulo-vesicular pool (Tty), can account for the above mentioned 
differences in recycling between GLUT4 and other proteins. It also allows for a very 
rapid translocation of GLUT4 to the plasma membrane and fits into the observation 
that the main effect of insulin is to increase the rate of exocytosis of GLUT4, rather 
than decrease the endocytosis rate (Slot et a l 1991a; Yang & Holman 1993). This 
model however involves only one plasma membrane pool of glucose transporter, and 
hence does not account for the presence of GLUT4 in clathrin coats (Slot et ai 1991a; 
Robinson et al. 1992) or more significantly for the time differences observed between 
appearance of GLUT4 at the plasma membrane and increase in glucose transport 
(Holman et al. 1994). Therefore the two different 4-pool models using occluded pools 
were proposed, where Tpo (Figuiel.3 C) represents vesicles that have docked with the 
plasma membrane, but not yet fused and Tpc (Figure 1.3 D) represents GLUT4 in 
clathrin-coated pits ready for endocytosis. It is important to note here that the ATB- 
BMPA can access GLUT4 in the occluded pool. The authors of the paper propose that 
the only possible way to explain all of the data about GLUT4 trafficking is through a 
5-pool or multiple-pool model (Figure 1.3E), which contains the two intracellular 
pools as well as the occluded pools (Holman et al. 1994).
The visualisation of GLUT4 compartments in a 3-D way has helped to distinguish 
between the intracellular GLUT4 pools (Ramm et al. 2000). As mentioned above, the 
majority of GLUT4 was targeted to small vesicles (~50nm in diameter), and this 
vesicular compartment was shown to be distinct from early and late endosomes as 
well as TGN. Co-localisation studies implied that, on one hand, a subset of these
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vesicles fuse with the plasma membrane in response to insulin, but that GLUT4 is 
also found in M6PR positive vesieles, and that insulin induced a sorting of GLUT4 
out of these vesicles.
The presence of two intiacellular pools of GLUT4 (the endosomal pool and highly 
insulin responsive pool) has also been confirmed biochemically, and some of the 
experiments will be discussed here.
Studies in rat adipocytes have suggested that GLUT4 containing vesicles are 
structurally (as well as functionally) different from other intracellular endosomes 
(Kandror et al. 1995). Many other studies have attempted to separate the insulin- 
sensitive GLUT4 storage vesicles (GSVs) from the endosomal pool. Sucrose density 
gradients (which exploit the different density properties of membranes) found two 
pools containing GLUT4 in rat skeletal muscle. Only one of these pools showed a 
30% decrease in GLUT4 levels due to insulin, whilst the other pool contained TfR 
(Aledo et al. 1997). The use of hypotonic lysis instead of homogenisation (as a 
method to fractionate cells) has also permitted the seperation of strongly insulin- 
sensitive cells (GSVs) from the less insulin-sensitive endosomes (Lee et al 1999).
More recently, an effective method used to separate the internal GLUT4 membranes 
in 3T3-L1 adipocytes is by the use of iodixanol as a gradient material (Hashiramoto & 
James 2000). Sucrose gradients have also been used to separate the internal 
membranes in 3T3-L1 adipocytes (Guilherme et al. 2000), and these two methods will 
be discussed in Chapter 3.
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?Another method, which has piven similar results, is compartment ablation. Here cells 
are loaded with transferrin bound to horseradish peroxidase (Tf-HRP), which is taken 
into the cell via the transfenin receptor. Incubation of intact cells with 
diaminobenzadine (DAB) and hydrogen peroxide allows HRP to transfer electrons 
from DAB to peroxide. This produces a highly reactive cross-linker within the lumen 
of transferrin receptor positive vesicles/ tubules, and thus any protein in proximity to 
the transferrin receptor is ablated (Livingstone et al 1996). Both GLUTl and the 
transferrin receptor were ablated by about 70% after 2h incubation with Tf-HRP, 
whilst GLUT4 was ablated by only 40%. This would imply that the larger proportion 
of GLUT4 (60%) is localised to a TfR-negative compartment, which was also devoid 
of the endosomal markers rab5 and M6PR (Livingstone et a l 1996). This data 
supports the kinetic and gradient studies mentioned above, and confirms the idea that 
GLUT4 is loealised in two intracellular compartments, one being the endosomes and "
the other being the GSVs.
1.6.4 The GSV model
''t
The current model for the transport of GLUT4 is therefore that GLUT4 in the basal i!
state is present in an insulin responsive compartment, now termed GLUT4 storage 
vesicles (GSVs) (Figure 1.4). Insulin then causes a rapid translocation of GLUT4 to
'k.the plasma membrane. This occurs both via fusion of GLUT4 containing vesicles with f
the plasma membrane as well as the sorting of GLUT4 from an endosomal 
compartment. GLUT4 undergoes endocytosis from the plasma membrane, via 
clathrin-coated pits, and enters the recycling endosomes. From these endosomes,
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many proteins (such as TfR, GLUTl and M6PR) enter a continous recyclying 
pathway with the plasma membrane (cycle 1 in Figure 1.4).
However, in contrast to this a large proportion of GLUT4 enters an intracellular 
transport loop between the TGN and endosomes (cycle 2 in Figure 1.4). Here GLUT4 
is selectively targeted to a seemingly futile cycle that prevents it from entering the 
cell-surface recycling pathway of these other proteins. GLUT4 emerging from the 
TGN is contained within the specialised insulin sensitive GSVs. These either undergo 
trafficking to the plasma membrane (in the presence of insulin), or fuse with the 
recycling endosomes and undergo recycling through the TGN. If this recycling in 
cycle 2 (from Figure 1.4) did not occur, then the endosomal and TGN pools of 
GLUT4 would become depleted, and all of the GLUT4 would be found in GSVs in 
the absence of insulin.
1.6.5 GLUT4 defects in diabetes
As mentioned in section 1.3, a defective glucose transport is the main reason for 
insulin resistance in type 2 patients (Bonadonna et al. 1993; Bonadonna et al. 1996; 
Kelley et al. 1996). Decreased GLUT4 levels at the plasma membrane after insulin 
treatment could be due to defects in any stage of GLUT4 recycling, and this can 
therefore lead to the development of type 2 diabetes.
Garvey and co-workers have studied GLUT4 levels and trafficking in both adipocytes 
and muscle cells from type 2 diabetic patients. Although in adipocytes GLUT4 down 
regulation can explain most of the decrease in insulin-stimulated glucose uptake 
(Garvey et al 1991), there is a discrepancy between the amoimt of transporters found
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at the plasma membrane and glucose transport (Garvey et al. 1988). This could be 
because these patients have a defect in their GLUT4 activity, meaning that although 
GLUT4 is present at the plasma membrane it is not funetional. It could also mean that 
GLUT4 is not inserted conectly into the plasma membrane, and therefore not 
transporting glucose (the transporter may be docked to the plasma membrane, but not 
yet fused).
A study from the same laboratory in muscle from insulin-resistant patients also 
suggested that GLUT4 was mis-targeted and that this could be the reason why insulin 
was unable to recruit GLUT4 to the plasma membrane (Garvey et al. 1998). 
Interestingly, in these insulin-resistant patients, GLUT4 was mis-targeted to a fraction 
that also contained plasma membrane and this is therefore similar to the study in 
adipocytes described above.
1.6.6 GLUT4 knock out mice
The generation of GLUT4 knock out mice led to the surprising discovery that GLUT4 
is not actually required for maintaining nearly normal blood glucose levels (Katz et al. 
1995). These mice are growth-retarted and have decreased longevity, but are not 
diabetic. It was demonstrated that GLUTl, the only other glucose transporter present 
in fat and muscle cells, was not upregulated. However, GLUT2 was upregulated in 
liver, and this is believed to demonstrate an increased uptake of glucose into this 
organ (reviewed in Muecklejr & Holman 1995).
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1.7 TRAP
Significantly, heterozygous knockout mice for GLUT4 (in contrast to the 
homozygous knockout mentioned above) develop a diabetic phenotype (Stenbit et al.
1997). It is believed that the reason for this is that these mice produce normal levels of
:GLUT4 until they are 8 weeks old, but then GLUT4 content declines. As a result of 
this, the heterozygous mice do not develop the compensating mechanism seen in 
GLUT4 null mice, and therefore can not deal with the decreased glucose uptake into 
peripheral tissue.
IRAP (vpl65) is an aminopeptidase, which was first cloned from rat adipocytes 
(Keller et al. 1995), and has been found to colocalise with GLUT4 in rat adipocytes 
(Malide et al. 1997c), 3T3-L1 adipocytes (Ross et al. 1996) and rat skeletal muscle 
(Aledo et al. 1997). It has been shown through immunoadsorption experiments of 
both GLUT4 vesicles and IRAP vesicles that these two proteins colocalise perfectly in
Ji:
the basal state in 3T3-L1 adipocytes (Ross et al. 1996). Through subcellular 
fractionation it has been discovered that IRAP translocates to the plasma membrane to
a similar extent as GLUT 4 in both 3T3-L1 adipocytes (Ross et al. 1996) and rat 
adipocytes (Malide et al. 1997c). Biotinylation experiments showed that the increase 
at the plasma membrane due to insulin to be about 8-fold (Ross et al. 1996). Confocal 
microscopy of rat adipocytes using double labelling with GLUT4 and IRAP indicated 
an overlap of about 85% between the two proteins (Malide et al. 1997c). This was 
also seen using electron microscopy on GLUT4 or IRAP vesicles, which revealed a 
70-90% overlap depending on cell type (Martin et al. 1997). Ablation experiments
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determined that IRAP was ablated to a similar extent as GLUT4, indicating that it 
(like GLUT4) is localised within two or more intracellular compartments (Martin et 
al. 1997). IRAP, in parallel with GLUT4, recycles constantly between the plasma 
membrane and intracellular membranes, and is endocytosed via clathrin coated pits 
(Garza & Birnbaum 2000). A number of studies have endorsed the idea that GLUT4 
and IRAP recycle through the endocytic pathway in a very similar way (Malide et al. 
1997c; Ross et al. 1997; Garza & Birnbaum 2000).
The exact function of IRAP, and specifically the role that it may play in the regulation 
of GLUT4 translocation, is fiowever unknown at present. The injection of IRAP (and 
particularly a 28 amino acid sequence of the cytoplasmic tail of the protein) into 3T3~ 
LI adipocytes causes GLUT4 translocation in the absence of insulin (The N-terminus 
of IRAP contains a di-leucine motif and several acidic regions similar to those that 
occur in Glut4. The similarity between the C-terminus of Glut4 and the N-terminus of 
IRAP suggests that these two molecules are sorted within the cell by a common 
mechanism). This movement to the plasma membrane could not be inhibited by 
wortmannin, the PI3-kinase inhibitor. These results indicate that the action of IRAP 
on GLUT4 is downstream of PÏ3-kinase activity (Waters et al. 1997). One theory 
from these results is that retention/ sorting proteins may interact with the C-terminus 
of GLUT4 and/or the N-terminus of IRAP. Injecting IRAP peptides into cells causes 
competition between these peptides and the intracellular IRAP for the retention/ 
sorting proteins and thereby translocation of the GLUT4 vesicles to the plasma 
membrane occurs (Waters et a l 1997). This data was supported by the generation of a 
chimeric reporter molecule vpTR, which contains the N-terminal cytoplasmic domain 
of IRAP and the transmembrane and extracellular domains of the transferrin receptor.
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and behaves much like IRAP. A mutation in the di-leucine motif in the cytoplamsic 
domain of vpTR established that this motif interacts with the machinery responsible 
for insulin-regulated intracellular retention (Johnson et al. 1998; Subtil et al. 2000).
Recently it has been proposed that IRAP may have a role to play in the association of 
the putative rabGAP AS 160 (Akt substrate of 160 kDa) with GLUT4 vesicles 
(Larance et al. 2005). It has been shown (both in vivo and in vitro) that AS 160 
interacts with the cytosolic tail of IRAP, which could account for this association. 
However, this association is seen only in the basal state, and is lost in response to 
insulin when AS 160 is phosphorylated by PKB. It has therefore been postulated that 
this interaction allows the GAP activity of AS 160 to maintain a key rab protein in the 
inactive GDP-bound form. It is proposed that once AS 160 is phosphorylated, it 
dissociates from the GLUT4 vesicles, and tins then allows for GTP loading of one (or 
more) rab protein leading ultimately to docking and fusing of GLUT4 vesicles with 
the plasma membrane (Laranee et al. 2005). Thus a role for IRAP could be insuring 
the intracellular localisation of GLUT4 in the basal state by interacting with AS 160.
A physiological function of IRAP has been hypothesized to be hormonal modulation 
of circulating vasoactive peptides such as vasopressin (Herbst et al. 1997). The 
aminopeptidases homologous to IRAP are constitutively expressed at the cell surface 
and as such, have continued access to their extracellular substrates (Kemiy 1986). 
IRAP however, in the basal state, is sequestered intracellularly and as such has limited 
access to its extracellular substrates. Therefore, it is expected to process its 
extracellular substrates only after translocation to the cell surface, upon insulin 
stimulation. In support of this, it has been shown that insulin, in parallel with the
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translocation of IRAP to the plasma membrane, increases aminopeptidase activity 
toward extracellular vasopressin in isolated adipocytes (Herbst et al. 1997). Thus, 
insulin, by bringing IRAP to the cell surface, could increase the processing of 
extracellular peptide hormones and thereby change their activities.
In individuals with type II diabetes, the msulin-stimulated translocation of IRAP to 
the cell surface of muscle and fat cells is impaired. This defect may lead to decreased 
cleavage and consequently increased action of peptide hormones that are substrates 
for IRAP. Impaired IRAP action may thus play a role in the development of 
complications in type II diabetes. This theory is supported by the finding that in mice 
where IRAP was deleted, decreased expression of GLUT4 and the enlargement of the 
heart (both common findings in patients with type II diabetes) aie seen. This suggests 
that impaired IRAP function at the plasma membrane may lead to complications in 
insulin resistant individuals (Keller 2004).
1.8 Other molecules in GLUT4 vesicles
VAMP/ Cellubrevin
Both vesicle-associated membrane protein 2 (VAMP2) and cellubrevin/ VAMPS have 
been found on GLUT4 vesicles (Cain et a/. 1992; Volchuk et al. 1995; Tamori et al. 
1996; Martin et al. 1996; Malide et al. 1997a). These proteins are important for the 
SNARE-type mechanism of GLUT4 translocation to the plasma membrane, and will 
be discussed in detail below. Both VAMP2 and cellubrevin display insulin-simulated 
translocation to the plasma membrane (Cain et a/. 1992; Volchuk et al. 1995; Tamori
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et a l 1996; Martin et al 1996). A number of studies have determined that VAMP2 is 
important in the translocation of the GSVs to the plasma membrane, whilst 
cellubrevin plays a role in the endosomal translocation of GLUT4 and other proteins. 
The use of an IgA protease, which cleaves VAMP2 but not cellubrevin, blocked the 
majority of insulin-stimulated GLUT4 translocation (Cheatham et a/. 1996). Also, the 
introduction of GST-VAMP2 into permeabilised adipocytes caused an inhibition of 
insulin-stimulated GLUT4 translocation (Cheatham et a/. 1996; Martin et al 1998; 
Millar et a l 1999), while in contrast GST-cellubrevin had no effect on insulin- 
stimulated GLUT4 translocation (Martin et a l 1998). GLUT4 translocation in 3T3-L1 
adipocytes was also inhibited by 40-50% when they were treated with an N-terminal 
peptide of VAMP2 (Macaulay et a/. 1997; Olsen et a l 1997; Martin et al 1998) and 
this same peptide was without effect on insulin-stimulated GLUTl translocation 
(Martin et al 1998). Conversely GST-cellubrevin inhibits insulin-stimulated GLUTl 
translocation partially (Millar et al 1999). From all of this evidence it was proposed 
that cellubrevin is important in the translocation of endosomal proteins (such as 
GLUTl) to the plasma membrane, whilst VAMP2 acts to specifically regulate the 
docking of GSVs in response to insulin.
Sortilin
Sortilin is a llOkDa protein that was originally found by its presence in GLUT4 
vesicles of adipocytes (Morris et al. 1998). Insulin causes only a veiy small 
redistribution of sortilin from the LDM to the plasma membrane in 3T3-L1 
adipocytes, which is surprising due to its presence in GLUT4 vesicles. This however 
could be because most of the sortilin may be in GLUT4 vesicles arising from
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endosomes, rather than from the GSVs (Morris et al. 1998). Thus far a role for sortilin 
in GLUT4 trafficking has not been identified.
1.9 The SNARE hypothesis
The SNARE hypothesis provides a conceptual framework to explain how synaptic 
vesicles dock and fuse to the plasma membrane. This model states that the vesicle that 
is intended to fuse with the membrane contains a protein called a vesicle-SNARE (v- 
SNARE) and that the target membrane contains a tai’get-SNARE (t-SNARE). 
Complementary v-SNARE and t-SNARE pairs aie able to engage, and this could staid 
the fusion event (Sollner et a l 1993a). It has been determined that all SNARE 
proteins share a homologous domain of -60 amino acids that is referred to as the 
SNARE motif (Terrian & White 1997; Weimbs et al 1997; Weimbs et al 1998), 
which combine to form the SNARE complex (this will be discussed below). Several 
other proteins are also believed to be involved in the process, and will be discussed 
below.
One of these proteins is NSF (N-ethylmaleimide-sensitive factor (Block et al 1988). 
NSF is an ATPase that can bind several other proteins in the ATP bound state (Wilson 
et aL 1992) and NSF activity is required for membrane fusion to occur (Whiteheart et 
al. 1994). In the original experiments, which led to the formation of the SNARE 
hypothesis, Rothman and colleagues assembled a so-called 20S particle using NSF in 
the ATP bound state as baif. Five proteins were discovered to be part of the 20S 
complex: NSF, a-SNAP, syntaxin, SNAP25 and synaptobrevin/VAMP2 (Sollner et
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al. 1993a and b). VAMP, syntaxin and SNAP25 are called SNAREs (soluble NSF 
attacliment protein receptors) and it was determined that they can form a complex 
even in the absence of NSF and a-SNAP (Sollner et al. 1993b). When ATP was 
added to the 20S complex, it was hydrolysed by NSF and the complex was 
disassembled.
Many different isoforms of the SNAREs have since been identified, leading to the 
belief that the formation of a SNARE complex is an obligatory step in all membrane 
fusion (Bock et al. 1996; Advani et al. 1998; Prekeris et al. 1998). VAMPS are 
located on the cytoplasmic surface of vesicles (therefore named v-SNAREs) and aie 
anchored in the membrane via their hydrophobic C-terminus, which contains a 
membrane- spamiing domain (Trimble et al. 1988). Syntaxin and SNAP 25 are 
located in the taiget or plasma membrane (Sollner et al. 1993b) and are hence called t- 
SNAREs.
The original SNARE hypothesis proposed that pairing of the v-SNARE with the t- 
SNAREs results in vesicle docking at the plasma membrane, and that this complex 
must be broken up in order for fusion to occur. As a consequence of the fact that these 
three SNARE proteins can foim a stable complex, an energy input is needed for this 
to happen. This was believed to be the reason why ATP hydrolysis by NSF, with the 
help of a-SNAP, is required. Consequent studies have indicated that this is an over­
simplified view, and only accurate in parts. A modified model for SNARE complex 
function will be discussed below.
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1.9.1 Evidence for the role pf SNARE proteins and their specificity
Experiments using eight different botulinum and tetanus toxins provided evidence in 
favour of a role for these proteins in membrane fusion. These toxins act to inliibit 
synaptic vesicle exocytosis, and hence block nerve function. The toxins are proteases, 
five of which can cleave VAMP, two cleave SNAP25 and one cleaves syntaxin (as 
reviewed in Südhof 1995). However, these proteins can only be cleaved before 
assembly of the SNARE complex, and not when the complex has been formed 
(Hayashi et al. 1994). This indicates that the cleaving sites are not available to the 
toxins once the complex has formed. The cleavage of VAMP using these toxins 
resulted in inhibition of neurotransmitter release in the squid giant synapse, but 
increased the amount of docked synaptic vesicles. Taken together this evidence 
suggests that VAMP is not important in the docking of the vesicles, but that it has a 
later, post-docking function (Hunt et al. 1994).
Analysis of SNARE function in an in vitro assay demonstrated that the interaction of 
SNAREs on distinct vesicle populations promoted vesicle-vesicle fusion (Weber et al.
1998). This report gave rise to the so-called SNAREpin model of fusion, in which the 
SNARE proteins represent the minimal machinery necessary for membrane fusion. 
Although current models support the view that SNAREs mediate membrane hision 
(or function just upstream ft'om fusion), it is clear that SNAREs alone are not 
sufficient for membrane fusion in vivo., and that a large number of other accessory 
proteins are required for effective exocytosis.
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1.9.2 The structure of the SNARE complex
The crystal structure of tfie SNARE complex of syntaxin 1 A, synaptobrevin 2 
(VAMP2) and SNAP25 has been solved (Sutton et al. 1998) (Figure 1.5). Prior to this 
discoveiy, it was already known that the SNARE proteins form coiled coils (Chapman 
et al. 1994) and that syntaxin and synaptobrevin lie parallel to each other when in the 
complex (Flanson et al. 1997). This is relatively suprising, because both syntaxin and 
synaptobrevin/ VAMP are anchored in their respective membranes via their C- 
terminus. However, this position of the SNARE proteins brings the two opposite 
membranes in close proximity and this may help to drive the fusion of the 
membranes. The crystal structure revealed that the synaptic fusion complex is 
arranged as a cylinder consisting of one helix from both syntaxin and synaptobrevin, 
and of two helices from SNAP25 (Figure 1.5). The helices are positioned such that the 
N-termini are at one end of the bundle, and the C-termini at the other end. SNAP25 is 
not an integral membrane protein (it is bound to the membrane by palmitylation of 
cysteine residues present near the middle of the sequence (Chapman et al. 1994)), and 
thus has a linker region between the two helices. This linker region traverses the 
length of the cylinder. It is also of note that inside the coiled-coil, there is a highly 
conserved hydrophilic layer made of an arginine (R) residue from synaptobrevin, and 
three glutamine (Q) residues, one from syntaxin and two from SNAP25 (one from 
each helix). These residues are thought to stabilise each other and are sealed away 
from the surrounding solvent by a hydrophilic layer. For this reason, 
synaptobrevin/VAMP is sometimes called an R-SNARE and syntaxin and SNAP25 
are called Q-SNAREs. Initially it was not cleai* why these polar residues are in the 
middle of the complex, but it has been demonstrated that they are required in order to
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get efficient disassembly of the SNARE complex by a-SNAP and NSF (Scales et al. 
2001). The SNARE complex is exceptionally stable and resistant to treatment with 
SDS which would usually be sufficient to dissociate other macromolecular 
complexes.
1.9.3 Syntaxin
Syntaxin was originally discovered as a consequence of its ability to bind to 
synaptogamin/p65 (Bennet et al. 1992), a synaptic vesicle protein important in 
calcium sensing (as reviewed in Südhof 1995). Syntaxin was cloned from rat brain 
and two isoforms were found, p35A and p35B (syntaxin lA and IB) both of which 
were found to be present largely at the plasma membrane at the site of
neurotransmitter release (Bermet et al. 1992). Syntaxin is an integral membrane 
protein, with a short transmembrane region at the C-terminus of the protein (Bennet et 
al. 1992; Kee et al. 1995). The cytoplasmic region of syntaxin contains 4 coiled coil 
domains of which the one closest to the tiansmembrane region (H3) is the most 
important for binding VAMP, a-SNAP and SNAP25 (Calakos et al. 1994; Chapman 
et al. 1994; Kee et al. 1995; Hanson et al. 1995). Mutational studies of syntaxin have 
shown that the VAMP-syntaxin interaction is very specific and sensitive to mutations, 
whereas the interaction of SNAP25 with syntaxin is much less specific (Kee et al.
1995). Both the H3 region (Wu et al. 1999) and the N-terminal Habc helical region of 
syntaxin 1A can bind synaptogamin in a Ca^  ^manner, and this is part of the calcium 
trigger in neurotransmitter release (Fernandez et al. 1998).
One protein thought to be important in SNARE complex regulation that can bind 
syntaxin is nsecl/munc 18. This protein requires both the H3 region and the N-
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terminal Habc helical region of syntaxinlA for binding, and thus prevents the binding 
of syntaxin to the other SNARE proteins (Pevsner et al. 1994, Kee et al. 1995; 
Fernandez et al. 1998). Recently the ciystal structure of the munclSa-syntaxinlA 
structiu'e has been identified (Figure 1.6) (Misura et al. 2000). The crystal structure 
showed that when syntaxinlA is in complex with munc 18a, that the Habc helical 
region of syntaxinlA is brought into close proximity with the H3 helix involved in 
interacting with VAMP and SNAP25, and consequently prevents SNARE complex 
formation. It is therefore believed that syntaxin can form three different 
conformations, one in isolation, one in the SNARE complex, and a third when bound 
to mime 18a (Misura et al. 2000).
There are many non-neuronal forms of syntaxin, and syntaxin is involved not only 
with fusion of vesicles with the plasma membrane, but also in trafficking between 
various membrane compartments, such as ER to Golgi, and Golgi to endosomes 
(Bock et al. 1996; Advani et al. 1998; Prekeris et al. 1998; Tang et al. 1998). The non 
neuronal isofrom syntaxin4 is important in the translocation of GLUT4 and will be 
discussed in detail below.
1.9.4 VAMP
VAMPl was originally cloned from the brain of a cartilaginous fish and found to be 
predominantly present on the synaptic vesicles (Trimble et al 1988). This protein has 
a molecular mass of 13KDa,^nd can be divided into three structural domains. The C- 
terminus is hydrophobic and spans the vesicle membrane, and the N-termmal domain, 
which contains a proline-rich sequence, and a long hydrophilic stretch, is exposed to 
the cytoplasm (Trimble et al. 1988). Many homologues of VAMP have been
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identified, varying in length, and not all of them have this proline-rich N-terminus 
(Advani et al. 1988). As detailed above, VAMP can bind both syntaxin and SNAP25 
(Sollner et al. 1993b) via coiled-coil regions, but the individual interaetions between 
both proteins are relatively weak, and it was shown that SNAP25-syntaxin 
heterodimers form a high affinity binding site for VAMP (Chapman et al. 1994; 
Hayashi et al. 1994). Unlike syntaxin, VAMP does not bind a-SNAP directly 
(McMahon & Südhof 1995; Hanson et al. 1995) and this suggests a post-docking role 
for a-SNAP (McMahon & Südhof 1995).
to play a role in the assembly of the SNARE complex, and were suggested to act as a 
catalyst (Sogaard et al. 1994).
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1.9.5 The regulation of the SNARE complex and Munc 18/nsecl
Undoubtedly the regulation of the formation of the SNARE complex is crucial to 
permit the fusion of the correct vesicles with the target membrane. Rab proteins are 
believed to play a role in regulating the specificity of vesicle trafficking events, and 
the large number of rab proteins present would make them suitable candidates for 
SNARE complex regulation (as reviewed in Lin & Scheller 2000). Although rab 
proteins are not part of the SNARE complex (Sollner et al. 1993b), they are believed
s
Another important regulatory protein of SNARE complex formation is Munc 18. This
■■'K.
protein is part of the Seel/Munc 18 protein family (SM proteins). These proteins are |
~60kDa in size and show homology throughout their sequence, indicating no 
particular domain is associated with their primary function. The first SM protein to be 
identified was UNC-18 in a genetic screen for uncoordinated phenotypes in C.
I
suggests that a mechanism n^ust exist in order to dissociate or alter the conformation 
of the Munc 18a so as to permit SNARE complex formation (Misui’a et ah 2000).
elegans (Brenner 1974). Seel was later identified in screens for genes involved in the 
yeast secretory family. The mammalian homologue, munc 18a, was identified by 
virtue of its ability to bind syntaxin 1 (Hata et al. 1993). It has since been discovered
' - i -
that all types of intracellular membrane traffic require an SM protein (for a review see le
Jahn et al. 1999; Jahn & Südhof 1999).
Munc 18a/nSecl is the neuronal homologue of the yeast protein sec Ip, and it is 
known to be important in neurotransmitter release (as reviewed in Lin & Scheller 
2000). Munc 18 has been shown to bind to syntaxin alone, but not to syntaxin in the 
SNARE complex, and the binding of Munc 18 to syntaxin inhibits the formation of 
the syntaxin-VAMP-SNAP25 complex (Pevsner et al. 1994). An interesting discovery 
is that phosphorylation of Munc 18 by PKC inhibits the Munc 18-syntaxin interaction, 
and this may facilitate the formation of the SNARE complex (Fujita et al. 1996).
A recent elucidation was the three dimensional structure of the complex of
:
syntaxinlA with nSecl/ munc 18a (Misura et al. 2000). Interaction between the two 
proteins is complex, involving both the N- and C- terminal cytoplasmic domain of 
syntaxin, and the whole of Munc 18. The munc 18a was seen to be an arch-shaped 
molecule, divided into three domains, with a central cavity. This central cavity 
provides the binding surface for syntaxinlA. SyntaxinlA binds to this surface making 
extensive contacts through the Habc domain and the SNARE motif. This interaction
therefore prevents the syntaxinlA protein from forming a SNARE complex, and
3
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A structure-based sequence alignment (of four SM proteins with Munc 18a, and four 
syntaxin proteins with syntaxinlA) identified that most of the interactions between 
syntaxinlA and Munc 18a are largely conserved throughout the Seel and syntaxin
Ilike proteins, A smaller number of interactions are not conserved among Seel family
members, and this may cqntribute to the binding specificity between a particular p
'■■ii
...I : :  I .Seel-like protein and its partner syntaxin (Misura et a l 2000). One such pair is munc 
18c and syntaxind, and the importance of munc 18c in translocation of GLUT4 will 
be discussed below.
Dissociation of the syntaxin-munc 18 complex is believed to be brought ahout by a 
conformational change in munc 18, and is probably mediated by other protein(s) such 
as rab or a rab effector. Two proteins that have been implicated in mediating the 
transition between the syntaxin 1-Munc 18a complex and the SNARE complex are 
UNO-13/ Munc 13 and Rab3 interacting molecule (RIM). Munc 13 was shown to 
interact with an amino-terminal region of syntaxinl (Betz et al 1997), and in 
C.Elegans, UNC-13 displaces syntaxin from UNC-18 (Sassa et a l 1999). RIM and
7Munc 13 have been shown to interact functionally, suggesting a role for RIM in 
regulating the primary activity of Munc 13 (Betz et al 2001).
3:
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iIt was thought originally that all SM proteins functioned by binding to closed 
conformations of syntaxins. However recent discoveries have shown this not to be the
;
case. Seel binds to core complexes containing the plasma membrane syntaxin Ssol, 
rather than to isolated Ssol (Carr et al. 1999). Furthermore, the yeast and mammalian 
syntaxins that function at the TGN and in early endosomes (Tlg2/syntaxinl6), and in Ir?
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Tethering of the vesicles on the membrane oecurs by a process of which there is 
limited knowledge, probably involving rab proteins and their effectors. The exocyst 
complex has also been implicated in either the tethering or docking of exocytotic 
vesicles (Lipschutz & Mostov 2002). The yeast exocyst complex consists of eight 
proteins: Sec3, Sec5, Sec6, gdcS, SeclO, Seel5, Exo70 and Exo84. Recent evidence 
has suggested a role for this complex in the fusion of GLUT4 vesicles with the plasma
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the endoplasmic reticulum (Ufel/syntaxin 18) and the Golgi (Sed5/syntaxin5) bind
;|tightly to their corresponding SM proteins (Vps45 and Slyl) through a short amino- 
terminal motif (Yamaguchi et al. 2002; Dulubova et al. 2002). The crystal structure of 
the SM protein Slyl showed considerable conservation, and had the same arch-shape, 
to that of Munc 18a. However, here the Sed5 does not bind to the central cavity of the 
SM protein (unlike syntaxinlA), but instead to the outer surface of one of the domains 
(Bracher & Weissenhorn 2002). This binding pattern is very different from the 
syntaxin 1 -Munc 18a interaction, and is compatible with core complex foimation and 
may recruit SM proteins to the sites of fusion, permitting SM proteins and SNAREs to 
carry out active functions simultaneously.
1.9.6 The docking and fusion of vesicles with the membrane
The release of neurotransmitter into the presynaptic cleft, and indeed many other 
processes involving the fusion of vesicles with target membranes, initiates with the 
translocation of those vesicles to the membrane (Figure 1.7). Attachment of these 
vesicles to the membrane can be divided into two stages: tethering and docking (as 
reviewed in Foster & Klip 2000).
$
membrane (Inoue et al. 2003). A number of studies have however established that 
neither SNARE proteins nor NSF and a-SNAP are required for this tethering step 
(Hunt et al. 1994; DeBello et a/. 1995; McMahon & Südhof 1995; Nichols et al. 1997)
$The formation of the SNARE complex then docks the vesieles to the plasma 
membrane and leads ultimately to membrane fusion. Syntaxin is initially in the closed
conformation, bound to Munc 18 as described above. A conformational change in 
Munc 18, mediated by other proteins, allows syntaxin to now form a SNARE ||
complex with VAMP and SNAP25. This brings the two membranes into close 
proximity and leads to fusion by a mechanism not clearly understood. S
1.:
Disassembly of the SNARE complex is knovm to involve NSF and a-SNAP (Hayashi 
et al. 1995; Nagiec et al. 1995; Barnard et al. 1997; Rice & Brunger 1999), but in 
contrast to the original SNARE hypothesis, NSF and a-SNAP are not required for the 
fusion itself (Nichols et al. 1997). Instead NSF and a-SNAP are required to 
disassemble the cis SNARE complexes, using the ATPase activity of NSF, which 
recycles the SNARE proteins for a further round of exocytosis.
Evidence from yeast vacuolar fusion has shown that NSF and a-SNAP are involved in |
a pre-docking stage (Mayer et al. 1996). This is unexpected, but could be explained 
by the suggestion that NSF and a-SNAP are necessary for the disassembly of cis 
SNARE complexes that occur after membrane fusion. In order for a new cycle of 
vesicle fusion to occur, the complex of SNARE proteins has to be disassembled and i
the proteins recycled to their correct location (as reviewed in Lin & Scheller 2000).
However, NSF has also been identified in a complex with rab 5 and EEAl, and it was 
suggested that NSF could prime SNARE proteins before fusion (McBride et al. 1999).
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Evidently more research is needed in order to further determine the full function of 
the proteins involved in the translocation and fusion of vesicles with their target 
membrane.
1.10 SNARE proteins in GLUT4 translocation
Despite GLUT4 exocytosis being a much slower process than neurotransmitter 
release, it resembles this process in a number of ways. In both proeesses, vesicles 
containing cargo are stored intracellularly until a signal triggers their translocation to 
the plasma membrane. For neurotransmitter release this signal is entry of calcium into 
the cell, whilst in GLUT4 exocytosis the signal is the binding of insulin to its 
receptor, and the consequent signalling cascade. Docking of vesicles at the plasma 
membrane then leads to fusion and release of cargo either into the synaptic cleft (in 
neurotransmitter release) or by insertion of GLUT4 into the plasma membrane. The 
similarity of the two mechanisms led to the search for a SNARE type mechanism in 
insulin sensitive tissue, and resulted in a more detailed knowledge of GLUT4 
translocation in these cells.
Homologues of many SNARE proteins have been identified in fat and muscle cells. 
VAMP2 and cellubrevin (a VAMP homologue) have been found in rat adipocytes 
(Cain et aL 1992; Martin et al. 1996), 3T3-L1 adipocytes (Tamori et al. 1996; Martin 
et al. 1996) and muscle cells (Volchuk et al. 1994; Kristiansen et a/. 1996). The use of 
Clostridial botulinum neurotoxins has demonstrated that cleavage of cellubrevin and 
VAMP2 will inhibit insulin-mediated GLUT4 translocation (Cheatham et a/. 1996;
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Macaulay et al.1991). The use of an IgA protease, which cleaves VAMP2 but not 
cellubrevin, also blocked the majority of insulin-stimulated GLUT4 translocation 
(Cheatham et a/. 1996). Also, the introduction of GST-VAMP2 into permeabilised
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adipocytes caused an inhibition of insulin-stimulated GLUT4 translocation (Cheatham
et a/. 1996; Martin et al. 1998; Millar et al. 1999), while in contrast GST-cellubrevin S3
had no effeet on insulin-stimulated GLUT4 translocation (Martin et al. 1998). GLUT4 
translocation in 3T3-L1 adipocytes was also inhibited by 40-50% when they were 
treated with an N-terminal peptide of VAMP2 (Macaulay et a/. 1997; Olsen et al. 
1997; Martin et al. 1998) and this same peptide was without effect on insulin- 
stimulated GLUTl translocation (Martin et al. 1998). Conversely GST-cellubrevin 
inhibits insulin-stimulated GLUTl translocation partially (Millar et al. 1999). From 
this evidence it was proposed that cellubrevin is important in the translocation of 
endosomal proteins (such as GLUTl) to the plasma membrane, whilst VAMP2 acts to
•f
specifically regulate the docking of GSVs in response to insulin.
There has been much research directed on identifying the exact intracellular location 
of both VAMP2 and cellubrevin. Both proteins translocate from intracellular stores to
the plasma membrane in response to insulin and are found in GLUT4 vesicles (Cain et
%al. 1992; Martin et al, 1996; Tamori et al. 1996; Timmers et al. 1996). Endosome 73
ablation determined that cellubrevin was ablated to a similar degree as TfR, whilst
VAMP2 was only ablated by around 10%. This data and vesicle adsorption together 
.with ablation indicate that cellubrevin is enriched in the endosomal GLUT4 vesicles.
whilst VAMP2 is present in the GSVs (Martin et al. 1996).
__
Evidence for the presence of SNAP25 in adipocytes is uncertain, but two SNAP25 
homologues called SNAP23 and syndet have been identified, and shown to be 
expressed in fat and muscle tissue (Ravichandran et al. 1996; Wong et al. 1997; Araki 
et al. 1997; Rea et al. 1998). Both proteins are predominantly located within the 
plasma membrane fraction, as expected (Wong et al. 1997; Araki et al. 1997; Rea et 
al. 1998).
i
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Syntaxin4 is expressed in a number of tissues, and high levels of the protein were 
found at the plasma membrane in adipocytes (Timmers et al. 1996; Tellam et al.
1997) and muscle (Volchuk et al. 1996). Lower levels of syntaxin4 were also found in 7
intracellular membranes (Timmers et al. 1996; Tellam et al. 1997) and from there it 
apparently undergoes translocation to the plasma membrane in response to insulin in a 
similar manner to GLUT4 (Tellam et al. 1997).
Insulin stimulated glucose transport was shown to be inhibited by injection of either 
antibodies to syntaxin4 (Tellam et al. 1997) or of a syntaxin4 peptide into adipocytes 
(Macaulay et al. 1997; Olson et al. 1997). Likewise the treatment of permeabilised 7;
3T3-L1 adipocytes with GST-syntaxin4 caused the inhibition of insulin stimulated 
GLUT4 translocation (Cheatham et al. 1996). However the introduction of a 
cytoplasmic syntaxin4 peptide into cells did not inhibit insulin mediated GLUTl 
translocation (Olson et al. 1997). Taken together, this supports a specific role for 
syntaxin4 in GLUT4 vesicle fusion at the plasma membrane.
An antibody to syndet as well as a C-terminal peptide have been shown to inhibit 
insulin stimulated GLUT4 translocation by 40%, but did not inhibit GLUTl 
translocation (Rea et al. 1998). The use of yeast two hybrid studies revealed that
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SNAP23 can bind strongly to syntaxinl and 4 (Araki et al. 1997) as well as VAMPl 
and 2 (Ravichandran et al. 1996). Similarly, surface plasmon resonance experiments 
have shown that syndet can bind syntaxin4 and VAMP2 individually and that this is 
disrupted by 0.5% SDS, while incubation of all three proteins together resulted in a 
0.5% SDS resistant complex formation (Rea et al. 1998).
Screening of rat adipocytes for a-SNAP and NSF deteimined that both proteins are 
intracellularly located, and to a substantial extent are present on GLUT4 vesicles 
(Mastick a/. 1997).
It is believed that in insulin-sensitive tissues, GLUT4 translocation occurs via a 
SNARE type mechanism, similar to neuronal cells, involving the formation of a 
complex made of syntaxin4, VAMP2, syndet/SNAP23 as well as a-SNAP and NSF. 
Furthermore the formation of a 20 S SNARE complex in vitro has been confirmed and 
shown to be independent of insulin treatment (St-Denis et al. 1999).
Regulation of SNARE mechanism in GLUT4 translocation
The importance of a SNARE mechanism for GLUT4 translocation presents a question 
of how it is regulated and how insulin affects the mechanism. As mentioned 
previously, there are a number of proteins important for the regulation of the SNARE 
complex. One such protein is Munc 18, of which several isoforms exist (Tellam et al. 
1995). Munc 18c is ubiquitously expressed, and its subcellular location in adipocytes 
is almost identical to that of syntaxin4 with highest levels found in the plasma
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membrane fiaction, and lower levels in the LDM fraction (Tellam et al. 1997). In 
vitro binding studies demonstrated that Munc 18c bound strongly to syntaxin4 
(Tellam et al. 1997; Tamori et al. 1998) and that it was able to reduce the association 
of syntaxin4 and VAMP2 by 75%. Munc 18c was also able to reduce the binding of 
cellubrevin to syntaxin4 by 60% (Tellam et al. 1997). Co-immunoprecipitation 
experiments demonstrated that syntaxin4 can bind both SNAP23 and Munc 18c in 
vivo, but that Munc 18c decreases the affinity of syntaxin4 for SNAP23 (Araki et al. 
1997).
Overexpression of Munc 18c in 3T3-L1 adipocytes inhibits insulin-stimulated 
GLUT4 translocation, but not that of GLUTl (Tamori et al. 1998), suggesting an 
inhibitory role for munc 18c. Similarly, microinjection of antibodies to Munc 18c into 
3T3-L1 cells stimulated GLUT4 translocation (Macaulay et al. 2002).
These munc 18c-syntaxin4 interactions have been demonstrated to be lost upon insulin 
stimulation (Thurmond et al. 1998), which again suggests that munc 18c has an 
inhibitory role, preventing SNARE complex formation until the correct signal (the 
presence of insulin) is received.
In contrast, the introduction into adipocytes of a peptide fragment of Munc 18c 
(18c/pep3) that inhibits the binding of Munc 18c to syntaxin4 resulted in inhibition of 
insulin-stimulated integration of GLUT4 vesicles into the plasma membrane 
(Thurmond et al. 2000), which suggests that the interaction between Munc 18c and 
syntaxin4 is required for this process. In these cells, GLUT4 vesicles were found just 
below the membrane, though unable to undergo fusion. It is however thought that this 
peptide may be derived from a region that does not directly contact syntaxin but 
instead represents Rab or Rab effector binding sites whose conformations are critical
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to syntaxin binding (Misura et al. 2000; Bracher & Weissenhorn 2002). Thus, this 
peptide may induce some other effects on Rab or Rab effectors in addition to 
disrupting the association between synatxin4 and Munc 18c. Thus the exact function of 
munc 18c in GLUT4 transloc^tion is not certain.
Another SNARE complex regulator is synip (Min et al. 1999). Synip is a syntaxin4 
binding protein, and its expression is restricted to adipocyte and muscle cells. Synip 
binding to syntaxin4 prevents VAMP2 from interacting with syntaxin4, but not 
SNAP23/syntaxin4 binding (Min et al. 1999). Interestingly in the presence of insulin 
the affinity of synip for syntaxin4 is reduced, implying that this protein is an insulin- 
sensitive regulator for GLUT4 translocation. This theory is supported by the fact that 
a C-terminal peptide of synip can inhibit insulin-mediated GLUT4 but not GLUTl 
translocation. It is believed that the N-terminus of synip may contain a regulatory 
domain, which causes the insulin-mediated decrease of syntaxin-synip interaction, 
thereby allowing SNARE complex formation and subsequent fusion of the GSVs with 
the plasma membrane (reviewed in Bennet 1999).
A further protein identified in insulin-sensitive eells is the cysteine-string protein 
Cspl (Chamberlain et a/.2001). This protein interacts with syntaxin4 in 3T3-L1 
adipocytes, and it has been proposed that it may be a chaperone of syntaxin4, 
regulating the conformational status of the protein.
Two proteins have been identified that interact with VAMP2, and proposed to prevent 
the entry of the v-SNARE info the SNARE complex in the absence of insulin. These 
proteins are pantophysin (Brooks et al 2000) and VAP33 (vesicle-associated protein
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33) (Foster et al 2000), although the mechanism by which this regulation occurs is 
unknown.
From these studies it is therefore evident that the SNARE mechanism is absolutely 
vital for GLUT4 entry into the plasma membrane and subsequent glucose transport. 
Decreased insulin-stimulated glucose uptake due to a defect in GLUT4 translocation 
could therefore be explained by a fault in the SNARE mechanism.
Aims of this Study
The first objective of this study was to initially repeat the experiment, using ducrose 3;
gradients, in order to isolate GSVs fiom 3T3-L1 adipocytes. It was intended then to 
further characterise these GSVs by determining whether a number of proteins co- 
localise with GLUT4, and whether any co-localisation was seen to be with the GSVs
. . Ïor the endosomal GLUT4 vesicles. It was also an aim to identify any proteins found ^
to be exclusive to GSVs via a number of gel-staining techniques. If these methods 3
proved successful using 3T3-L1 adipocytes, it was then an objective to carry out
similar analysis in other cell-types, in order to identify any proteins native to GSVs f
from different cell-types. Any such proteins are likely to be of significance.
,g
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In Chapter 4, we aimed to produce a mutated form of the neuronal munc 18a, in order 
to alter its syntaxin-binding properties to become more like munc 18c, which has an 
inhibitory role to play in GLUT4 translocation to the plasma membrane. If the 3^'
mutations were successful in allowing interaction with syntaxin4 to occur, it was then f
iproposed to produce a reconjbinant Adenovirus construct (of the mutated protein) to
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drive expression in mammalian cells. If this step was successful, it was then an 
objective to overexpress the munc 18 in insulin sensitive cells in order to determine 
whether the mutated munc 18 protein, with its altered syntaxin-binding properties,
M '..had any effect upon glucose transport. This could make it possible to establish the
importance of the munc 18c-syntaxin4 interaction on GLUT4 integration into the 
plasma membrane.
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Figure 1.1 Insulin signalling pathways in insulin mediated glucose uptake (from 
Kanzaki & Pessin 2003)
Shown opposite are the two insulin signalling pathways involved in the translocation 
of GLUT4 containing vesicles to the plasma membrane. ‘Signal 1’ represents the 
classical PI3-kinase pathway, where the insulin receptor uses 1RS proteins to activate 
PI3-kinase, leading ultimately to the activation of PKB and atypical PKC.
‘Signal 2’ represents the PI3-kinase independent pathway. Here upon insulin binding 
its receptor, ultimately the TCIO GTPase is activated. It is believed that a downstream 
target for TCIO could be the exocyst complex, and that the TCI 0-exocyst complex is 
then responsible for targeting GLUT4-containing vesicles to appropriate plasma 
membrane fusion sites.
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Figure 1.2 Glucose transporter structure
A schematic model for the transmembrane organisation of a GLUT is shown opposite. 
Shown are the twelve membrane-spanning helices, and the loops between helices 1 
and 2, and 6 and 7. Note that both the N- and C-terminus are intracellular.
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Figure 1.3 Membrane-prot^in recycling models (Holman et a l 1994)
A In the 2-pool model, the fully functional plasma membrane protein (Tp) is in 
equilibrium with only one intracellular pool (Tee). B In the 3-pool model, two distinct 
intracellular pools are designated. These are the early endosomal pool (Tee), and the 
tubulo-vesicular compartment (Ttv). C and D In the 4-pool models, occluded forms 
are added to the plasma membrane occurring either before (Tpo, C) or after (Tpg, D) 
the fully functional plasma membrane pool. E In the 5-pool model, two occluded 
plasma membrane pools are included, in addition to the two intracellular pools.
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Figure 1.4 GLUT4 trafficking in cells (from Bryant et aL 2002)
Shown is a schematic representation of GLUT4 trafficking. GLUT4 (and other 
proteins such as transferrin receptor) are internalised from the plasma membrane 
(PM) into endosomes, from where they are packaged into recycling endosomes. Most 
of the transferrin receptor, but only a low percentage of GLUT4 then recycles back to 
the plasma membrane (cycle 1).
GLUT4 is packed into specialised GLUT4 storage vesicles (GSVs) from the TGN. In 
the absence of insulin the GSVs may fiise with endosomes, accounting for the 
appearance of a small pool pf GLUT4 in endosomes, even in the absence of insulin 
(cycle 2). hi the presence of insulin however, these GSVs fuse with the PM, and 
therefore insertion of GLUT4 into the PM occurs.
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Figure 1.5 Crystal structure of the synaptic fusion complex (Sutton et al. 1998)
The SNARE complex is formed from four helices, one from syntaxin (red), one from 
VAMP/synaptobrevin (blue) and two from SNAP25 (green) form a coiled-coil 
structure. The 4 helices are arranged in a parallel manner. The transmembrane 
domains of VAMP/synaptobrevin and syntaxin are included (yellow) as well as the 
linker region of SNAP25 (brown). Note here that the illustrated helices form only a 
part of each protein.
54
Figure 1.5
SNAP-25
Synaptobrevin
Syntaxin
m a m - ^I Plasma membrane
55
Figure 1.6 The munc 18a-syntaxinla complex crystal structure (from Misura et 
al. 2000).
The figures opposite show the crystal structure of the interaction between the SM 
protein munc 18a and syntaxinlA (a and b show the same structure, but with a 90° 
rotation about the vertical axis). Domain 1 (of munc 18a) is shown in blue, domain 2 
in green and domain 3 in yellow. The three domains form an arch-shaped structure.
The Habc domain of syntaxinlA is shown in red, the H3 domain (which can form part 
of the SNARE complex) is shown in purple and the linker region between these two is 
shown in orange.
Note here that syntaxinlA binds in the groove formed by the arch-shape of the three 
munc 18a domains, and that when the complex is formed the Habc and H3 domains of 
syntaxinlA are in close proximity. This is thought to represent the “closed” 
conformation of synatxinl that prevents SNARE complex formation.
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Figure 1.7 Model for the docking and fusion of vesicles with the plasma 
membrane
Syntaxin is initially in the ‘closed’ conformation, bound to the nsecl/munc 18. This 
interaction prevents SNARE complex formation. Action of a Rab/ Rab effector then 
causes a conformational change in nsecl, and a loss of interaction with syntaxin. As a 
result, the v-SNARE and t-SNARE proteins can form A SNARE complex, and 
membrane fusion occurs.
After fusion occurs, NSF and a-SNAP are required to disassemble the c/^'-SNARE 
complexes that remain on the same mebrane. This requires the ATP-ase activity of 
NSF, and allows the SNARE proteins to be recycled for a further round of fusion.
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CHAPTER 2 -  MATERIALS AND METHODS
2.1 Materials
All reagents used in the course of the project were of a high quality and were obtained 
from the following suppliers:
2.1.1 General Reagents
Anachem Ltd, Luton, Bedfordshire, UK
30% aciylamide/bisacrylamide
Bio-Rad Laboratories Ltd, Pemel Hempsted, Hertfordshire, UK
N, N, N% N’-tetramethylethylenediamine (TEMED)
Boehringer Mannheim, Germany
Tris
Protease Inhibitor cocktail tablets
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Amersham International Pic, Aylesbury, Buckinghamshire, UK
Horseradish peroxidase (HRP)-conjugated donkey anti-rabbit IgG antibody 
Horseradish peroxidase (HRP)-conjugated sheep anti-mouse IgG antibody 
ECL Western blotting detecting reagents 
ECL plus Western blotting detecting reagents 
Glutathione Sepharose 4B
  _   :::
Fisher Ltd, Loughborough, Leicestershire, UK
Ammonium persulfate
Diaminoethanetetra-acetie acid, Disodium salt (EDTA)
Disodium hydrogen orthophosfate (Na2HP04)
Glycerol
Glycine
N-2-hydroxyethylpiperazine-N' -2-ethanesulphonic acid (HEPES) 
Hydrochloric Acid (HCl)
Methanol
Potassium Chloride (KCl)
Potassium Dihydrogen orthophosfate (KH2PO4)
Sodium dodecyl sulfate (SDS)
Sodium Chloride (NaCl)
Sucrose
Kodak Ltd, Hemel Hempsted, Hertfordshire, UK
X-Omat S film
Merck Ltd (BDH), Lutterworth, Leicestershire, UK
Magnesium Chloride (MgCl2)
Tween 20
New England Biolabs (UK) Ltd, Hitchin, Hertfordshire, UK
Prestained protein marker, broad range (6-175kDa)
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Novo Nordisk, Denmark
Insulin
Nycomed, Norway
OptiPrep^^ (lodixanol)
Quiagen, Crawley, West Sussex, UK
Ni-NTA Agarose
Schleicher & Schuell, Dassel, Germany
Nitrocellulose membrane (pore size: 0.45pM)
2.1.2 Cell Culture Materials
American Type Culture Collection, Rockville, USA
3T3-L1 fibroblasts
Gibco BRL, Paisley, UK
Foetal bovine serum (PBS)
New born calf serum (NCS)
Dulbecco’s modified Eagle’s medium (without sodium pyruvate, with 4500mg/L 
glucose) (DMEM)
Opti-MEM
10000 U/ml penicillin, lOOOOU/ml streptomycin
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Trypsin/EDTA solution 
Costar
75cm^ cell culture flasks 
Falcon
10cm cell culture plates
Bibby Sterlin Ltd, Stone, Staffordshire, UK
Sterile pipettes
Unless inidicated all other reagents were obtained from Sigma Chemical Company, 
Dorset, UK
2.2 General Buffers 
Phosphate Buffered Saline (PBS)
137mM NaCl, 2.6mM KCl, 1 OmM Na2HP04, 1.7mM KH2PO4 (pH 7.4)
Homogenisation Buffer (HES)
255mM sucrose, 20mM HEPES, ImM EDTA (pH 7.4)
Sucrose Gradient Buffer
20 mM HEPES, 100 mM NaCl, 1 mM EDTA (pH 7.4)
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SDS PAGE Buffers 
Electrode Buffer
25mM Tris base, 192mM glycine, 0.1%(w/v) SDS 
Sample Buffer
93mM Tris.HCl; pH 6.8, ImM EDTA, 10% (v/v) glycerol, 2% (w/v) SDS, 0.002% 
(w/v) bromophenol blue and (20mM dithiothreitol added immediately prior to use).
Western Blotting Buffers
PBS-T
PBS (pH7.4), 0.1% (v/v) Tween-20 
Transfer Buffer
25mM Tris base, 192mM glycine, 20% (v/v) methanol 
Protein Purification & Binding Buffers 
His6-tag Purification Buffer
5OmM imidazole, 20raM Hepes, 200mM KCl, 2mM (3-mercaptoethanol, 2mM 
MgCli,10% glycerol (pH 7.0)
Breaking Buffer
lOOmM HEPES, 5mM MgCE, 2mM p-mercaptoethanol, 500mM KCl (pH 7.0)
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GST Binding Buffer
20mM HEPES, lOOmM NaCl, ImM DTT (pH 7.4)
Ni^^-NTA Binding Buffer
150mM potassium acetate, ImM MgCl%, 0.05% (v/v) Tween-20, 20mM HEPES (pH 
7.4)
2.3 Cell Culture
2.3.1 3T3-L1 Murine Fibroblasts
and then differentiated into adipocytes.
2.3.2 Trypsination and Passage of 3T3-L1 Fibroblasts
Following aspiration of media from a 75cm^ flask, 1ml of trypsin/EDTA solution was 
added to wash the remaining media from the monolayer of cells. This was then 
removed and 3ml of fi'esh trypsin/EDTA solution were added and the flask was 
incubated at 37°C in a humidified atmosphere of 10% CO2 for 5 min. Careful 
agitation of the flask resulted in the cells being lifted from the surface of the flask.
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3T3-L1 fibroblasts were cultured in 75cm^ flasks containing DMEM/10% (v/v) 
newborn calf serum and 1% (v/v) penicillin and streptomycin. Cells were cultured at 
37°C in a humidified atmosphere of 10% CO2, and the media was replaced every 48 
h. When subconfluent (70-95% confluency) the cells were passaged into 10cm culture 
plates and a 75cm  ^carry over flask. Cells were cultured to 4 days post confluency,
i
..i
2.3.3 Differentiation of 3T3-L1 Fibroblasts
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This cell suspension was the added to a maximum volume of 230ml DMEM/10% 
(v/v) newborn calf serum and 1% (v/v) penicillin and streptomycin. With occasional 
agitation, the cells were then split between 10cm culture plates and 75cm^ flasks.-1 ■Fldolrc
' I-
■ «; i
Differentiation media of DMEM/ 10% (v/v) foetal bovine serum, 1% (v/v) penicillin 
and streptomycin, 0.25pM dexamethasone, 0.5mM methyl isobutylxanthine and 
1 pg/ml insulin was prepared as described below.
A stock of 2.5mM dexamethasone (in ethanol) was diluted 1:20 with DMEM/ 10% 
(v/v) foetal bovine serum, 1% (v/v) penicillin and streptomycin immediately prior to 
use yielding a 500X stock solution. A 500X sterile solution of methyl 
isobutylxanthine (IBMX) was prepared by dissolving 55.6mg IBMX in 1ml of 2M 
KOH and passing the solution through a 0.22 micron filter. Insulin (1 mg/ml) was 
prepared in 0.01 M HCl and filter sterilised using a 0.22 micron filter as before. 
Differentiation media was prepared by adding both the dexamethasone & IBMX 
solutions to a IX coneentration in DMEM/ 10% (v/v) foetal bovine serum, 1% (v/v) 
penicillin and streptomycin and then adding insulin to a final concentration of Ipg/ml. ■7I
3T3-L1 fibroblasts were cultured on 10cm plates until 4 days post confluency. Then 
the grorvth media was aspirated and replaced with differentiation media. After 48 h, 
this media was replaced with DMEM/ 10% (v/v) foetal bovine serum, 1% (v/v) 
penicillin and streptomycin and insulin at Ipg/ml. The cells were incubated in this 
media for a further 48 h. Following differentiation, the media was replaced with
■I
DMEM/ 10% (v/v) foetal bovine serum, 1% (v/v) penicillin and streptomycin. The 
media Avas changed every 48 h and the cells were used 10-14 days post 
differentiation.
2.3.4 Freezing and Storage of Cells
Fibroblasts were cultured to 70-95% confluency, the media was aspirated and 1ml of 
trypsin/EDTA solution was added to wash the remaining media from the monolayer 
of cells. This was then aspirated, and 3ml of fresh trypsin/EDTA solution were added 
and the flask was incubated at 37°C in a humidified atmosphere of 10% CO2 for 5 
min. Careful agitation permitted the cells to be lifted from the surface of the flask. 
3 ml of DMEM/10% (v/v) newborn calf serum and 1% (v/v) penicillin and 
streptomycin were added to the cell suspension, and this was then transferred to a 
sterile tube and centrifuged at 2000 x g for 4 min. Following aspiration of the 
supernatant, the pellet was ‘flicked’ gently and then resuspended in 1ml of 
DMEM/10% (v/v) newborn calf serum, 1% (v/v) penicillin and streptomycin and 10% 
(v/v) DMSO. The suspension was then transferred to a 1.8ml polypropylene cryo-vial 
and place at -80°C overnight (wrapped in blue roll), before being stored in a liquid 
nitrogen vat.
2.3.5 Resurrection of Frozen Cell Stocks from Liquid Nitrogen
A vial of cells was removed from liquid nitrogen, transferred to a 37°C water bath and 
thawed. The cell suspension was then pipetted into a 75cm^ flask containing 
DMEM/10% (v/v) newborn calf serum and 1% (v/v) penicillin and streptomycin
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All reagents were of electrophoresis grade.
acrylamide/bisacrylamide, IM Tris-HCl (pH 6.8) (to a final concentration of 
125mM), 10% (w/v) SDS (to a final concentration of 0.1%), polymerised with 10% 
(w/v) ammonium persulphate (to a final concentration of 0.1%) and TEMED (to a 
final concentration of 0.05%).
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which had previously been equilibrated at 37°C in a humified atmosphere of 10% 
CO2. The media was replaced after 24 h and the cells were cultured as described 
before.
2.4 SDS/Poiyacrylainide GeJ Electrophoresis
SDS/polyacryalamide gel elecrtrophoresis was carried out using Bio rad mini- 
PROTEAN II gel apparatus. The percentage of acrylamide in each gel ranged 
between 7.5% - 15%, depending on the molecular weight of the protein(s) of interest.
Î
Upon assembly of the gel apparatus, the separating gel was prepared using 30%
,èacrylamide/bisacrylamide, 1.5M Tris-HCl (pH 8.8) (to a final concentration of 
375mM), 10% (w/v) SDS (to a final concentration of 0.1%), polymerised with 10%
I(w/v) ammonium persulphate (to a final concentration of 0.1%) and TEMED (to a 4
final concentration of 0.01%). The stacking gel was prepared using 30%
4
-- : '
Protein samples were resuspended in sample buffer, and loaded into wells in the 
stacking gel. lOpl of broad range pre-stained molecular weight markers were loaded 
into at least one well. Gels were immersed in electrode buffer and electrophoresed 4
until the dye front had reached the desired position or imtil adequate separation of pre-
'.ss:
stained molecular weight n^arkers. A constant voltage of 70 volts was applied 
through the stacking gel, which was increased to 120 volts through the resolving gel.
2.5 SDS/Polyacrylamide Gel Staining
2.5.1 Coomassie blue staining of protein gel
Following SDS/Polyacrylamide Gel Electrophoresis, a 0.25% Coomassie blue stain 
solution was prepared. For this, 10ml of glacial acetic acid was mixed with 90ml of a 
methanoliHiO (1:1 v/v) mixture and 0.25g of Brilliant Blue R were added. This stain 
was then filtered thi'ough Whatman filter paper. The gel was submerged in the stain 
for about Ih and destained with the same acetic acid, methanol: H2O mixture (without 
the dye) as above. Gels were destained for at least 3h or overnight, depending on 
resolution wanted. The destained gel was then scanned to record the results.
2.5.2 Sliver Staining
Following SDS/Polyacrylamide Gel Electrophoresis, the gel was submerged in 50% 
methanol/ 10% acetic acid for 30min. The gel was then placed in 5% methanol/ 7% 
acetic acid for a further 30min, before being washed several times with H2O over a 
30min period. The gel was submerged in 0.02% sodium thiosulfate for Imin, and then 
subsequently washed twice with H2O for Imin each. Following this, the gel was 
submerged for 30min in 0.2%AgNO3, with ImM formaldehyde, and gently rocked. 
The gel was then washed with H2O for Imin. In order to develop the stain a mixture of 
6% Na2C03 and 6mM formaldehyde were added and again gently rocked. When
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desired staining has occurred, this solution is discarded and replaced with 5% acetic 
acid. The gel can then be scanned & stored in 20% ethanol at 4°C.
2.5.3 Stains All Staining
'4 :
Following SDS/Polyacrylamide Gel Electrophoresis, the gel was submerged in 50% |
methanol/ 7% acetic acid overnight. The gel was then washed extensively in 25% 
propan-2-ol for 24hr. The propan-2-ol was then replaced with the stains all solution 
(3OmM Tris, 25% (v/v) propan-2-ol, 7.5% (v/v) fonnamide, adjusted to pH 8,8, 
followed by the addition of 0.025% (w/v) stains all) and incubated in a light-tight 
container for 24-48hr. In order to destain the gel, it was removed from this solution 
and exposed to light.
2.6 Western Blotting of Proteins
5
After separation of the proteins as described earlier, gels were removed from the
'
plates and equilibrated in Transfer buffer for 10 minutes. A sandwiched arrangement f
of components, individually soaked in Transfer buffer, were made as follows from 
bottom to top: brillo pad, two pieces of Whatman 3MM filter paper, nitrocellulose 
paper, equilibrated polyacrylamide gel, two pieces of Whatman 3MM filter paper, 
brillo pad. The sandwich was placed in a cassette and slotted, bottom nearest to 
cathode, into a Bio-Rad mini trans-blot tank filled with Transfer buffer. Transfer of 
proteins was performed at room temperature for 3 hours at a constant cuiTcnt of
250mA, or overnight at 40mA. Efficiency of transfer was determined by staining the 
nitrocellulose membrane with Ponceau S solution.
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Following transfer, the nitrocellulose membrane was incubated with 5% (w/v) dried 
skimmed milk made up in PBS-T for 1 hour to block non-specific binding sites. The 
membrane was then transferred to a plastic pocket containing primary antibody in 1 % 
(w/v) dried skimmed milk in PBS-T at the appropriate dilution and shaken for at least 
2h at room temperature. Following five washes with PBS-T over a period of 30 
minutes, the membrane was incubated in 1% (w/v) dried skimmed milk in PBS-T 
with the appropriate secondaiy antibody, (HRP-linked IgG) for Ih at room 
temperature. The blot was then washed for 15 minutes with PBS-T supplemented with
0.5M NaCl, followed by 3 changes over 15 minutes with PBS-T.
Following incubation with the appropriate HRP-linked IgG and subsequent washing, 
the membrane was washed in distilled HiO. The signal was then detected using ECL. 
Equal volumes of Amersham “detection reagent 1” and “detection reagent 2” were 
mixed and the membrane was immersed and shaken in this mixture for 60 s. The 
membrane was then ‘blotted’ diy, placed in a plastic pocket in a light tight cassette 
and exposed to Kodak film. The film was then developed using an X-OMAT 
processor.
2,7 Subcellular Fractionation of 3T3-L1 Adipocytes
Subcellular fractions (PM, HDM and LDM) were obtained as described for the 
fi-actionation of rat adipocytes by Piper et al. 1991, modified by Martin et al. 1994.
Cells cultiued on 10cm plates were either insulin treated (IpM insulin) or incubated at 
37°C in serum-free DMEM for 2h. Following the transfer of plates onto ice, the cells
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The resulting pellet was resuspended in 1ml ice-cold HES buffer and layered onto 
1ml of 1.12M sucrose in HES buffer in a Beckman tube and centrifuged at 100,000 x 
g for 60 min at 4°C in a swing out rotor. The upper layer was caiefully removed to 
leave a brown band at the interface (plasma membrane). This fraction was then 
diluted in HES buffer containing protease inhibitors and pelleted at 180,000 x g for 60 
min at 4°C.
(A simplified flow-chart of this protocol is shown in Figure 2.1)
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were washed 3 times with ice-cold HES buffer. On addition of 500pi/ plate of HES 
buffer containing protease inhibitors (protease inhibitor cocktail tablet from 
Boehringer Mannheim: 1 tablet used in 50ml) the cells were scraped and then 
homogenised with 20 strokes in a Bounce homogeniser. Homogenates were 
transferred to pre-chilled Oakiidge Beckman centrifuge tubes and centrifuged at
16,000 X g for 20 min at 4°C.
aMeanwhile, the supernatant from the initial spin was centrifuged at 46,000 x g for 20 
min at 4°C, yielding a pellet designated as the high density microsomal fraction 
(HDM). The resulting supernatant was centiifuged at 180,000 x g for 60 min at 4°C 
yielding a pellet designated the low density microsomal fraction (LDM). All 
membrane fractions were resuspended in HES buffer and snap frozen in liquid 
nitrogen and stored at -80°C prior to analysis.
2.8. lodixanol Gradients
OptiPrep is a sterile solution of lodixanol (5,’[(2-hydroxy-l-lpropanediyl)- 
bis(acetlamino)bis [N,N ’ -bis(2,3 dihydroxypropyl-2,4,6-triiodo-1,3 -benzenecarbox- 
amide].
inverted several times to ensure sufficient mixing, and then spun at 295,000 x g in a
Gradients were prepared as described by Hasliiramoto et al 2000 with slight changes.
.LDM membranes were prepared as described before and mixed with iodixanol to a 
final concentration of 14% (w/v). Volumes were made up to 3.9ml using HES Buffer 
and the mixture was sealed in quick-seal Beckman polyallomer tubes. Tubes were
near vertical rotor (Beckman, TEN 100) for 1 h at 4°C. Acceleration from 0 -  886 x g 
was set to be 5 min and deceleration was without breaks in order not to disturb the 
forming gradient. The tube was then pierced at the top (to allow air in) and then 300pl 
fractions were piereing the bottom of the tube.
All fractions were snap frozen in liquid nitrogen and stored at -80°C prior to analysis.
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2.9 Sucrose Gradients
Gradients were prepared as described by Guilherme et al 2000.
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LDM samples were prepared as described before and 1.5-2 mg of LDM fractions 
were loaded onto a 10-35% (w/v) continuous sucrose velocity gradient (in Sucrose 
Gradient Buffer) and centrifuged for 3.5 h at 105,000 x g at 4°C in a SW40 rotor 
(Beckman).
Fractions containing GLUT 4-membranes (fractions 4-10 typically) were pooled, 
pelleted by ultracentrifugation at 180,000 x g for 60 min at 4°C, and then resuspended 
in Sucrose Gradient Buffer. This was then loaded onto a 10-65% (w/v) continuous 
sucrose equilibrium density gradient (in Sucrose Gradient Buffer) and centrifuged at
218,000 X g for 18 h at 4°C in a SW40 rotor (Beckman). After centrifugation, 
fractions were collected starting from the top of the gradient.
2.10 Protein expression and purification
2.10.1 Munc 18 and syntaxin plasmids
The his6-tagged munc 18a and 18c (in plasmid pQE-30), and GST-syntaxin 4 (in
4,:plasmid pGEX-5Xl) were provided by Dr Luke Chamberlain (University of 
Glasgow). The GST-syntaxins 1,2 and 3 (in plasmid pGEX-KG) were obtained from 
Richard H. Scheller, Ph.D (Genentech).
Ï
The mutated form of hise-tagged munc 18a/c was made through three rounds of site- 
directed mutagenesis, using the primers indicated in the table below. These amino 
acids were selected by examining the 3D structure of the munc 18a- syntaxin 1 
interaction. Amino acids on the munc 18a believed to interact with syntaxin 1 (based 
on their close proximity) were noted, and then mutated to the corresponding amino 
acid of munc 18c when their sequences were aligned [The mutations were carried out 
in order IGEARV^KE, then T(52)E and finally Q(338)R]. The sequence of this new 
mime 18a/c was confirmed by automated sequencing before continuing with protein 
expression.
. ?: 
"4 
4-
-A
«
Mutated amino acids Base Changes 
(Muncl 8a—>Muncl 8a/c)
Primer Sequence (5’->3’) 
(mutated bases in bold & 
underlined)
T(52)E ACC->GAA CAG ACA TCA TGG AAG AGG GGA TCA
IGEARV->KE ATT GGA GAG GCG AGG 
GTG-> AAG GAG
CAA GTA TGA GAC CAG 
CGG CAA GGA GAA GGA 
GGT GCT CCT GGA TG
Q(338)R CCA->CCG GCC CCA GTA CCG GAA GGA GCT CAG
2.10.2 Protein expression
Competent E.coli JM109 cells [Genotype: el4-(McrA~) recAl endAl gyrA96 thi-1 
hsdR17(ïK- mK+) supE44 relAl A(lac-proAB) [F’ traD36proAB lacPZAM15] ] were 
transformed with the above constructs, and protein expression induced by growing the 
cells in 0.5mM IPTG for 4hr at 37°C. Cells were pelleted by centrifugation at 2,500 x 
g, then washed and resuspended in breaking buffer (containing ImM PMSF and a
..,4
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2.10.3 Protein purification
Hisô-tag Purification Buffer. The bacterial cell lysates were then loaded onto the Ni
column (12 x 1ml fractions collected) by applying a step gradient of increasing 
concentrations of imidazole in this buffer (ranging from 95mM-275mM). Peak 
fractions containing munc 18 proteins were identified by SDS-PAGE.
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protease inhibitor tablet [protease inhibitor cocktail tablet from Boehringer 
Mannheim: 1 tablet used in 50ml]) and this was stored overnight at -80°C. The cells 
were then thawed in cold water, and then lysozyme added (to a concentration of 
1 mg/ml) and left on ice for 30min. Following this the solution was ultrasonicated a 
total of three times. Cell debris was then pelleted by centrifugation at 43,000 x g for 
40min at 4°C, and the supernatants (containing the protein) were recovered.
;v
HiSô-tagged munc 18 proteins were purified by Ni^  ^ affinity cliromatography at 4°C.
;A 3ml Ni -NTA agarose column was first washed with 5ml dH^O, followed by 5ml
2+
NT A agarose column and passed through twice. The column was then washed with •
30ml FIis6-tag Purification Buffer. Following this, the proteins were eluted from the
" 'A
The GST-syntaxin proteins were purified using a Glutathione-Sepharose column at
-,
4°C. Initially the 3ml Glutathione-Sepharose column was washed with 10ml dH20, 
followed by 20ml cold PBS. The cell lysate was then loaded onto the column and 
incubated for Ih at 4°C. Following this the column was washed four times with 20ml 
cold PBS to remove non-bound protein. The GST-syntaxin proteins were then eluted 
from the column with lOmM reduced glutathione in 5OmM Tris, pH 8.0. 5 x 1.5ml 
fractions were collected.
2.11 Circular dichroism (CP) analysis
The work using CD analysis (in order to investigate protein structure and folding) was 
carried out by Dr Sharon Kelly and Professor Nick Price (from the Univeristy of 
Glasgow). Approximately Img/ml of each protein was required for Near UV analysis, 
and 0.3 mg/ml for Far UV analysis.
2.12 Munc 18-syntaxin binding studies 
GST-pull down assay
Glutathione beads were washed three times in GST Binding Buffer, and incubated 
with a protein extract from E.coli (approximately 0.2pg/pl of bead slurry) for Ih at 
4°C with end-over-end rotation. After washing the beads three times with the GST 
Binding Buffer, either 2pM of GST or GST-synatxin protein were added, and 
incubated at 4°C with end-over-end rotation.
An equivalent volume of hise-tagged munc 18 protein was then added to make a final 
concentration of IpM for munc 18 in a final reaction volume of 200pl, and the 
mixture was incubated for 2h at 4°C with end-over-end rotation. The beads were then 
washed twice with GST Binding Buffer containing 1 mg/ml gelatin, and three times 
with GST Binding Buffer containing 5% glycerol.
Any bound proteins were then eluted by boiling the beads in Sample Buffer. Eluted 
proteins were then separated by SDS-PAGE and transferred onto nitrocellulose for 
immunoblotting analysis.
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Ni^^-NTA agarose binding studies
2.13.1 Preparation for cloning into pShuttle-CMV
In order to successfully clone each munc 18 into the pShuttle-CMV vector it was first 
necessary to design primers (supplied by TAGN, Newcastle UK) to introduce suitable 
restriction sites at either end of the sequence, and a FLAG-tag sequence at the C 
terminus. The table below gjives details of the primers used in order to introduce the
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Ni^^-NTA agarose beads were washed three times in Ni '^^-NTA Binding Buffer, and 
incubated with a protein extract fiom E.coli (approximately 0.2pg/pl of bead slurry) 
for Ih at 4°C with end-over-end rotation. After washing the beads three times with the 
Ni^^-NTA Binding Buffer, 2pM of Hise-tag munc 18 protien was added, and 
incubated at 4°C with end-over-end rotation (there was also a control, with no Hise- 
tag munc 18 protien).
An equivalent volume of GST-synatxin protein was then added to make a final Iconcentration of 1 pM for syntaxin4 in a final reaction volume of 200pi, and the 
mixture was incubated for 2h at 4°C with end-over-end rotation. The beads were then
,7+ .washed twice with Ni -NTA Binding Buffer containing 1 mg/ml gelatin, and three 
times with Ni^^-NTA Binding Buffer containing 5% glycerol.
Any bound proteins were then eluted by boiling the beads in Sample Buffer. Eluted
4proteins were then separated by SDS-PAGE and transferred onto nitrocellulose for 
immunoblotting analysis.
2.13 Adenovirus Production
I
■J4
required restriction sites (to allow cloning into the multiple cloning site of pCR2.1 to 
occur) and the FLAG-tag. Following PCR, the product was TA cloned into vector 
pCR 2.1. The pCR2.1/munc 18 plasmid and the pShuttle-CMV were then digested 
with the relevant restriction enzymes and gel purified to permit ligation.
Primer Name Significance of base 
changes
Primer Sequence (5’->3’) 
(additional bases in bold)
Munc 18a + a/c forward Addition of Bgl//restriction 
site[AGATCT]atN- 
termiiius
AGA TCT ATG GCC CCC 
ATT GGC CTC
Munc 18a + a/c reverse Addition of FLAG-tag 
sequence and Hind III 
restriction site [AAG CTT] at 
C-terminus
AAG CTT TTA CTT GTC 
GTC GTC GTC CTT GTA
GTC ACT GCT TAT TTC 
TTC GTC TGT
Munc 18c forward Addition of Bam HI 
restriction site [GGA TCC] 
at N-terminus
GGA TCC ATG GCG CCG 
CCG GTA TCG
Munc 18c reverse
Addition of FLAG-tag 
sequence and Xho I  
restriction site [CTC CAG] at 
C-terminus
CTC CAG TTA CTT GTC 
GTC GTC GTC CTT GTA
GTC CTC ATC CTT AAA 
GGAAACTTT ATC
2,13.2 Ligation of munc 18 and pShuttle-CMV
5pi of each insert (munc 18), 2.5pl of plasmid (pShuttle-CMV), Ipl of Ligase Buffer 
and 1.5 pi of T4 DNA Ligase were incubated on half water/ half ice for 16hr to allow 
ligation to occur. 3 pi of the resulting mixture was then transformed into TOP 10 cells, 
and restriction digests of (DNA obtained from) selected colonies confirmed successful 
ligation.
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2.13.3 BJ5183 co-transformation
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Each recombinant pShuttle-CMV/munc 18 vector is first linearised using Pme 1, 
which is then heat inactivated, and the DNA gel purified. Following this, the DNA is " '?
mixed with pAd-Easy and then added to a 40 pi aliquot of electroporation competent 
BJ5183 cells [Genotype: endA ^Z>cBC recBC galK met thiA bioT hsdR. (St/)] and 
electroporation carried out under the following conditions: 200 Ohms, 25pF, 2.5kV.
This is immediately resuspended in SOC media and plated out on LB + kanamycin 
plates. Colonies aie selected and the DNA digested with Pac I to identify successful 
incorporation of the munc 18 into the p Ad-Easy.
2.13.4 DH5a transformation
The BJ5183 cells are not stable, and are prone to deletions, so it is necessary to 
transform the pAd-Easy/munc 18 into DH5a cells [Genotype: F- deoR recAl endAl 
hsdR\l(rk\ mk^] supEAA k thi-l gyrA96 relAl). 5pi of the recombinant DNA is |
added to 40pi of DH5a electrocompetent cells, and electroporated under the 
following conditions: 200 Ohms, 25pF, 2.5kV. This is immediately resuspended in 
SOC media and serial dilutions are plated out on LB + kanamycin plates. Colonies are 
selected and the DNA digested with Pac I to identify successful transformation into 
the DH5a cells.
2.13.5 Transfection of HEK 293 cells
20pg of each recombinant pAd-Easy/Munc 18 plasmid is then digested with Pac I, 
and extracted once with pfrenol/ chloroform and ethanol precipitated. The DNA is 
then resuspended in 50pl of TE O.IX.
When the HEK 293 cells are ready to be transfected, the DNA is diluted into 1ml of 
OPTI-MEM (serum free) and mixed gently. 40pl of Lipofectamine 2000 is then 
diluted into 1ml of OPTI-MEM (serum free) and incubated at room temperature for 5 
min. At this point the diluted DNA and diluted Lipofectamine 2000 are mixed gently 
and incubated for 20 min. A further 8ml of OPTI-MEM is then added to the mixture, 
which is added to the HEK 293 cells.
The next day this is aspirated off, and replaced with DMEM/5% (v/v) foetal bovine 
serum and 1% (v/v) Glutamine. Subsequent feeds are of DMEM/5% (v/v) foetal calf 
serum, 1% (v/v) Glutamine and 1% (v/v) penicillin and streptomycin.
After 10 days, the cells are spun down, resuspended in sterile PBS and subjected to 
freeze-thaw conditions in order to obtain the cell lysate. Aliquots of the lysate, media 
and membrane fraction are first removed (to analyse for expression of the Adenoviral 
protein) and the remainder is snap frozen and stored at -80“C.
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Figure 2.1 Flow chart of the protocol for the subcellular fractionation of 3T3-L1 
adipocytes
The flow chart opposite demonstrates the various centrifugation steps involved in 
obtaining each of the subcellular fractions from a crude cell homogenate.
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CHAPTER 3-SUCROSE GRADIENT ANALYSIS OF INTRACELLULAR 
GLUT4 STORES
3.1 Aims
1. To demonstrate the use of sucrose gradient centrifugation for resolving 
GLUT4 compartments in 3T3-L1 adipocytes
2. To characterise the GLUT4 storage vesicles
3.2 Introduction
Insulin stimulates the uptake of glucose into muscle and fat eells primarily due to the 
translocation of GLUT4 from intracellular membranes to the cell suiTace in the 
presence of insulin. In the absence of insulin, GLUT4 is found in both endosomes 
(-40%) and in specialised GLUT4 storage vesicles (GSV) (-60%) (Martin el at 
1997; Livingstone ei a t 1996). These GSVs are highly insulin sensitive and explain 
why GLUT4 shows a greater level of translocation to the cell surface (around 15-fold) 
than other endosomal proteins such as the transferrin receptor (TfR) and GLUTl 
(about 2-fold) (Tanner & Lienhard 1987; Piper et at 1991).
Although it was understood that GLUT4 is found in both endosomes and GSVs, it has 
been difficult to separate the two. The relative amounts of GLUT4 present in the
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endosomes and GSVs can be determined using endosomal ablation techniques 
(Livingstone et al. 1996) but does not resolve the compartments for purification 
purposes. One recent study has used iodixanol gradient centrifugation in order to 
separate the two vesicle populations (Hashiramoto & James 2000). Another study has 
made use of sucrose gradients (Guilherme et al. 2000), which although more time 
consuming may prove to be a more effective method of selective isolating GSVs. In 
3T3-L1 adipocytes, sucrose gradient centrifugation has been used to separate 
intracellular GLUT4-containing membranes into two distinct peaks, one containing 
the GSVs (peak 1) and the other being enriched in endosomal/TGN markers (peak 2).
In these studies we have characterised sucrose gradients in 3T3-L1 adipocytes with I
respect to GLUT4 and other proteins that partly co-Iocalise with GLUT4. We have 
demonstrated that is an effective way in which to resolve distinct intracellular GLUT4 
pools.
We have also used different gel staining teclmiques in order to characterise the GSV 
compartment. These techniques proved problematic though did identify one potential 
protein of interest.
1
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3.3 Results
3.3.1 Subcellular Fractionation
In order to obtain the LDMs needed for the sucrose gradients, it was first necessary to 
carry out a subcellular fractionation of 3T3-L1 adipocytes in both the basal and 
insulin stimulated state.
As can be seen from Figure 3.1, upon addition of insulin there is a marked reduction 
in the levels of both GLUT4 and IRAP in the LDM fraction, and a subsequent 
increase in levels of both at the plasma membrane as expected. Using this technique 
there is -2-fold change in levels of both GLUT4 and IRAP (a decrease in the LDM 
fraction, and increase in the plasma membrane fraction). These values for the fold 
increase at the plasma membrane are however significantly smaller than the 15-20 
fold changes obseived using other experimental techniques (Tanner and Lienhard 
1987; Calderhead et al 1990). This discrepancy is primarily due to difficulties in 
preventing contamination of the fractions during the various centrifugation steps.
However, these results do show the reduction in the levels of both GLUT4 and IRAP 
in the LDM fraction, and the subsequent increase at the plasma membrane of both 
proteins. Having demonstrated this effect we could then use these LDM fractions in 
order to segregate the GLUT4 compartments.
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33.2  Iodixanol Gradients
%
In order to visualise the two pools of GLUT4 (endosomal and GSV) it was originally 
intended to use the method of Hashiramoto and James, using iodixanol sedimentation 
analysis. Using this method, it had been possible to successfully isolate GSVs from 
the endosomal pool, and as such our aim was to repeat this in order to further ;|
characterise the GSVs.
However, when repeating this experiment, the expected results could not be obtained.
■ i-
It had been expected to see two distinct peaks of GLUT4 containing fractions, with
'Ipeak 1 being highly insulin responsive (and hence contain the GSVs). Instead our
Iresults showed GLUT4 to be present in fractions throughout the gradient. The 
experiment was repeated a number of times, with similar results. As such it was 
decided that an alternative method of isolating the GSVs should be attempted.
In addition, there has also been some uncertainty as to the effectiveness of iodixanol
■■-I
gradients using rat tissues, and as such it may not be an efficient method of 
selectivetly isolating GSVs from different tissues.
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3.3.3 Sucrose Gradients
Having abandoned the iodixanol gradient method, in order to resolve the two pools of 
GLUT4 we have used the method described by Guilherme et al using two sucrose 
gradients (Guilherme et a l 2000).
The first sucrose gradient (a velocity gradient) uses a continuous density gradient, I
with an increasing density towards the bottom of the tube. This is a relatively short 
gradient (compared to the equilibrium gradient) and separates molecules by their
molecular weight. This centrifugation step is able to isolate GLUT4 containing
membranes form the majority of other protein membranes in the crude LDM sample.
:7-
During the second sucrose gradient (the equilibrium gradient), the sucrose forms a |■s
gradient and molecules move to the position where their density is the same as the
sgradient material, and hence separation is due to density. This gradient takes ï
■Îsignificantly longer to run than the velocity gradient, and allows for a clearer
resolution of the sample.
Using the sucrose velocity gradient centrifugation (U^  sucrose gradient) it was 
possible to exclude the vast majority of the total membrane protein (fractions 1-3 
typically) from the GLUT4 enriched membranes (fractions 4-10 typically), as shown
■ 'Ü
in Figure 3.2 and Table 3.1. Here it is seen that whereas -70% of total membrane 
protein is found in fractions 1-3 (Table 3.1), the GLUT4 containing vesicles are 
predominantly in fractions 4-10 (Figure 3.2). At this stage there was no significant 
difference in the protein content between those fractions containing GLUT4 and
:IRAP in the presence or absence of insulin.
I
■'
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%These GLUT4 containing fractions were pooled, and subjected to sucrose equilibrium V
gradient centrifugation (2”^  sucrose gradient) in order to further resolve the membrane 
species present. Figure 3.3 shows the distribution of GLUT4 and IRAP after this 
equilibrium gradient, showing that both are found mainly in fractions 5-9.
These immunoblots however do not establish whether the two GLUT4 containing 
compartments have been isolated. In order to establish whether this has occurred, each 
of the GLUT4 and IRAP containing fraction must be compared both in the presence 
and absence of insulin stimulation.
In agreement with Guilherme et al., we discovered that insulin induced a greater loss 
of GLUT4 and IRAP from peak 1 than from peak 2 (Figure 3.4), which is consistent 
with the thinking that peak 1 contains the GLUT4 storage vesicles. Peak 2 is believed A
to contain the recycling endosomes, and in the presence of insulin GLUT4 and IRAP 
levels in this peak are seen to decrease by less than in peak 1. From the results here it 
was determined that, upon the addition of insulin, levels of GLUT4 and IRAP are 
seen to be reduced by -50% from the fractions in peak!. This is in contrast to a drop 
in levels of only 10-20% from the fractions in peak2. These findings are consistent 
with the idea that the endosomal GLUT4 vesicles are less insulin responsive than 
GSVs.
.
It is also important to note that the decrease in GLUT4 levels in fractions 5-7 upon 
insulin stimulation is mirrored by a similar decrease in the total protein concentration 
in these fractions (Table 3.2). At the same time, a much smaller decrease in total 
protein concentration is observed in fractions 8-9 upon insulin stimulation.
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3.3.4 Localisation of other proteins of interest
In order to further characterise the nature of the two separate GLUT4 peaks, we
Taken together, these results would indicate that after the sucrose equilibrium gradient 
centrifugation, we have successfully isolated GSVs from recycling endosomes. We 
have also excluded the vast majority of other membrane proteins, meaning that these 
fractions contain relatively pure GLUT4 vesicles (demonstrated by the faet that the 
large decrease in GLUT4 and IRAP levels in peak 1 is matched by a significant f
reduction in protein concentration, whereas there is less of a protein concentration
decrease in the less insulin-sensitive peak2 fractions).
; J
Having repeated the sucrose gradient experiments successfully, it was now possible to 
ascertain whether other proteins of interest co-localise with GSVs by cairying out 
immunoblot analysis (Figure 3.5) |
examined the distribution of the v-SNARE VAMP2. VAMP2 was found to co- I
segregate with the GSV peak (the majority found in fraction 6). It is also notable that 
upon insulin stimulation there is a large decrease in VAMP2 found in these LDM 
fractions. Taken together, this supports the data that VAMP2 is the v-SNARE for 
GSVs (Martin et a l 1996).
■r
Unlike GSVs, the transferrin receptor is known to undergo continual recycling {r,
between the plasma membrape and endosomes with only a small increase in plasma ;: |
membrane levels upon insulin stimulation. This was supported by the data from ï
Figure 3.5 that shows the transferrin receptor is localised in fractions 8-9 with only a |
i
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Lodish 1999), the results in Figure 3.5 show that ACRP30 may indeed co-localise 
with GLUT4, as they are present in the same fractions (fractions 8-9 predominantly). 
These results do not confirm a direct correlation between ACRP30 and GLUT4 
trafficking, as it could be that both proteins (by chance) happen to be present in
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slight decrease seen in response to insulin. This is therefore a good indication that the 
GLUT4 containing vesicles in fi'actions 8-9 represent the recycling endosomal pool. I
It is known that upon insulin stimulation of 3T3-L1 adipocytes, the secretion of a
Iprotein hormone ACRP30 (adipocyte complement related protein of 30 kD) is 
markedly enhanced. Like GLUT4, regulated exocytosis of ACRP30 appears to require 
PI3-kinase activity, since insulin-stimulated ACRP30 secretion is blocked by J■ mpharmacologic inhibitors of this enzyme (Bogan & Lodish 1999). We therefore sought 
to determine whether there was any co-localisation between ACRP30 and GLUT4. vl
t:
Although previous data would indicate that the secretion of ACRP30 is by a different
pathway than GLUT4 translocation, and these proteins do not co-localise (Bogan &
Ï
vesicles of a similar buoyant density. In order to confirm whether these proteins do |
indeed co-localise a further experiment could be to cany out immunoprécipitation of 
GLUT4 containing vesicles, and then check the resulting sample for presence of 
ACRP30 using SDS-PAGE and western blotting analysis. This was not attempted in 
the present study.
I
•I
Sec6 and Sec8 are two proteins that are part of the exocyst complex. The exocyst f
complex is an eight protein complex that has recently been implicated in GLUT ,||
- '?:■
exocytosis as a downstream target for TCIO (Kanzaki & Pessin 2003). The data from 
Figure 3.5 indicates the presence of both of these proteins in fractions 8-9, although it !
: |
1is difficult to establish whether insulin stimulation causes any significant change in 
the level of either protein. Although this co-loealisation does not demonstrate a 
definite role for these exocyst proteins in GLUT4 exocytosis, it does provide evidence 
that they are at least partly co-localised with some GLUT4 containing membranes.
3.3.5 Identification of a potential calcium-dependent kinase in GLUT4 
containing vesicles
the 2"  ^ gradient SDS-PAGE gels were stained using both silver stain (to identify 
proteins in general) and Stains All (to possibly identify calcium-binding proteins).
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In order to identify potential proteins of interest, GLUT4 containing fractions from
Ca^  ^has been shown to be involved in the insulin-stimulated transport of glucose in
3T3-L1 adipocytes (Whitehead et al. 2001). It was implicated that Ca^  ^ could have a 
role to play in both GLUT4 translocation to the plasma membrane, and also in the 
fusion of GLUT4 vesicles with the plasma membrane. Consequently any calcium- 
binding proteins located within GLUT4 vesicles would be of potential interest.
In the initial silver stain of the 2"  ^gradient fraction, the gels were stained with the aim 
to identify any proteins in the GLUT4 containing fractions whose protein levels were 
reduced in the presence of insulin, and thus could be of interest. Several SDS-PAGE 
gels were stained from a number of fractions, without identifying any such protein. As 
a result, another method of gel staining was used.
Stains-All, wliich stains calcium-binding proteins a blue/purple colour, identified one 
potential protein of interest. This protein produced a very feint band (mainly in peak
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2), and due to the light sensitivity of the dye an image could not be captured (even
when a larger volume of these fractions was loaded on SDS-PAGE gels). The
intensity of the band was the same in the presence and absence of insulin, implying 
.that i f  s abundance was unaltered after insulin treatment. The protein was ~50kDa in 
size, and was carefully cut out from the gel and identified by Mass Spectroscopy. The 
resultant data identified a protein of mass 57,3 54Da, identified as a possible 
Serine/Threonine Kinase protein, first identified by Schaar et al. 1996. As such it was 
hoped that cDNA and an antibody could be obtained in order to further analyse its 
localisation with GLUT4. However, we were unable to obtain this, and as such further 
analysis of this protein was not carried out.
It is important to note that this protein was primarily seen to be present in the fractions 
containing the endosomal/ TGN GLUT4 vesicles rather than those containing GSVs.
This study had aimed to identify proteins located exclusively in the GSVs, which 
could decrease the relevance of this finding. However, on the other hand, the fact that 
this protein was present (although in reduced levels) in the GSV containing fractions 
means that unless further analysis was carried out to establish its exact sub-cellular 
localisation, we are currently unable to exclude the possibility that this could be a 
potential protein of importance.
.i;:
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3.4 Discussion
It is known that insulin stimulates the uptake of glucose into muscle and fat cells due 
to an increase in the translocation of GLUT4 from intracellular membranes to the cell 
surface. Under basal conditions, GLUT4 is located in both endosomes (-40%) and 
specialised GLUT4 storage vesicles (GSVs) (-60%) (Martin et al. 1997; Livingstone 
et al. 1996), These GSVs are highly insulin sensitive and explain why GLUT4 shows 
a greater level of translocation to the cell surface (-15-fold) than other endosomal 
proteins such as TfR and GLUTl (~2-fold) (Tanner & Lienhard 1987; Piper et al. 
1991).
Although the presence of GLUT4 in both endosomes and GSVs is known, it has 
proved to be difficult to separate the two for analysis. Endosomal ablation techniques 
allow the relative amounts of GLUT4 present in each vesicle-type to be determined 
(Livingstone et al. 1996), but are unable to resolve the compartments for purification 
purposes. Two recent techniques developed in order to separate the two vesicle 
populations have been to use iodixanol gradient centrifugation (Hashiramoto & James 
2000), and also to use sucrose gradients (Guilherme et al. 2000).
A number of differences between GSVs and GLUT4 vesicles from recycling 
endosomes are already known. For example it is known that GSVs are smaller 
(~50nm in diameter), and have VAMP2, rather than cellubrevin found in recycling 
endosomes, acting as a v-SNARE on them. The current study aimed to add to our 
knowledge of the composition of GSVs, and to identify proteins which could be 
significant.
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Initially we sought to use the iodixanol gradient technique in order to isolate GSVs 
from the endosomal GLUT4 containing vesicles and then to characterise the GSVs. 
Having first repeated this experiment in 3T3-L1 adipocytes, it was then proposed to 
do likewise for other cell-types in order to identify proteins of interest that may be 
common to GSVs from different cell-types. However, as discussed in Section 3.3.2, 
the results obtained from the iodixanol gradient in this study did not match the 
expected results. As such, it was decided to attempt the sucrose gradient technique (as 
described by Guilherme et al) as an alernative. It is important to note that there has
peakl than from peak2. Levels of both of these proteins are seen to be reduced by 
-50% from peak 1 (upon addition of insulin), compared to a reduction of only 10- 
20% in levels from fractions in peak 2 (Figure 3.4). This supports the argument that 
peakl contains the GSVs, while peak 2 contains the recycling endomes (Guilherme et 
al 2000).
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been some uncertainty as the effectiveness of the iodixanol gradient technique when 
using rat tissues, and as such it may not be an efficient method of selectively isolating 
GSVs from different tissues.
In the present study, we have confirmed the use of these two sucrose gradients as an 
efficient method to separate the endosomal GLUT4 compartments and GSVs. We 
have confirmed that 3T3-L1 adipocyte LDM samples can be separated into two peaks, 
as seen in Figuie 3.4, with one being higlily insulin responsive (mirrored by a similar 
decrease in protein concentration) and the other being less insulin responsive (with a 
smaller decrease in protein concentration identified).
.In response to insulin, the loss of GLUT4 and IRAP is seen to be much greater from
ii;
"I
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In agreement with this, VAMP2 (the v-SNARE present in GSVs) is found in the
Jfractions of peakl only. Levels of VAMP2 are, like GLUT4 and IRAP, reduced in 
response to insulin. Also, the presence of TfR in peak2 fractions only is a good :•
indication that vesicles from these fractions contain recycling endosomes (Figure 3.5).
Both of these findings support peakl as containing GSVs, and peak2 the recycling 
endosomes.
Om* studies have also demonstrated that two proteins that foim the exocyst complex 
(Sec6 and Sec8) are found to co-localise with GLUT4 (Figure 3.5). This protein 
complex has recently been implicated as having a role to play in GLUT4 translocation 
and tethering to the plasma membrane (Inoue et al 2003) as a downstream target of 
TCIO from the PI3-kinase independent insulin-signalling pathway. While not 
eonfirming a role for the exocyst complex in GLUT4 trafficking, the data here 
suggests at least the complex is located to a similar intracellular location as some of 
the GLUT4 containing vesicles. 1;'
i
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Results in the present study have also suggested that there may be some co­
localisation between GLUT4 and ACRP30. This finding was in conflict with previous 
findings (Bogan & Lodish 1999), which indicated secretion of ACRP30 was via a 
different pathway than GLUT4 translocation and as such there would be no co-
..'i.
localisation. Further analysis (such as a co-immunoprecipitation) would have to be
■I -
carried out in order to confirm whether GLUT4 and ACRP30 do indeed co-localise, 
or if they are only, by chance, found in vesicles of similar buoyancy.
:S
Using a technique to stain for potential calcium binding proteins, we have identified a a
finding has permitted initial experiments to take place to establish that there does
potential calcium-binding protein kinase in GLUT4 containing vesicles. This was of
■Ï:;interest due to the fact it is known that Ca^  ^ is required for membrane fusion in 
neurotransmitters, and more recently it has been identified as having a possible role in 
the fusion of GLUT4 with the plasma membrane (Whitehead et al. 2001).
Unfortunately, as we were unable to obtain cDNA or an antibody for this protein we 
were unable to investigate this protein, and whether it does indeed co-localise with 
GLUT4, in further detail.
In conclusion we have confirmed the use of sucrose gradients as being an effective 
tool to study GLUT4 trafficking. We have demonstrated that by using this method it ;
is possible to isolate GSVs from the recycling endosomal pool of GLUT4. Tins
seem to be co-localiastion of exocyst complex with GLUT4, and also a potential co- ■ f
Ilocalisation of ACRP30 with GLUT4. Further analysis would have to be carried out in
order to confirm whether this is indeed the case.
We have also been able to identify the presence of a potential calcium binding 
Serine/Threonine kinase within GLUT4 containing vesicles, although we have been 
unable to investigate the protein any further.
I
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Figure 3.1 GLUT4 and IRAP are translocated from the LDM to PM upon 
insulin stimulation.
3T3-L1 adipocytes are either treated with (+) or without (-) IjiiM insulin for 30min. 
Subcellular fraction was carried out as described in the Methods section. 1 Opg of each 
fraction were separated by SDS-PAGE. This experiment was repeated 3 times, and 
shown are typical immunoblots for the proteins indicated.
[For IRAP, the secondary antibody was HRP-conj ugated donkey anti-mouse IgG, and 
for GLUT4, it was HRP-conj ugated donkey anti-rabbit IgG antibody]
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Figure 3.2 Sucrose velocity gradient analysis of GLUT4 and IRAP in 3T3-L1 
adipocytes.
3T3-L1 adipocytes are either treated with or without IpM insulin for 30min. LDM 
fractions were prepared and subjected to sucrose velocity gradient analysis as 
described in the Methods section. 1ml fractions were collected from the top of the 
gradient and 15pl of each fraction were separated by SDS-PAGE. The results shown 
are from a single gradient analysis, and are representative of three experiments. 
Typically fractions 4-10 were the GLUT4 peak fractions.
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Figure 3.2
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Table 3.1 Protein profile of sucrose velocity gradient fractions
3T3-L1 adipocytes are either treated with or without IpM insulin for 30min. LDM 
fractions were prepared and subjected to sucrose velocity gradient analysis as 
described in the Methods section. 1ml fractions were collected from the top of the 
gradient, and then each fraction assayed for its protein coneentration. The results 
shown (on the table opposite) are from a single gradient analysis, and are 
representative of three experiments.
Note that although fractions 4-10 (in bold) were found to be the GLUT4 containing 
fractions (see Figure 3.2), most of the membrane proteins (-70%) are found in 
fractions 1-3 and hence not pooled for the 2"^  ^ gradient. Note also that there are no 
significant differences between the protein concentration levels of the peak fractions 
whether or not the cells are stimulated with insulin.
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Table 3.1
Fraction No. Non-insulin stimulated cells 
(protein concentration mg/ml)
Insulin stimulated cells 
(protein concentration mg/ml)
1 0.78 0.71
2 0.42 0.39
3 0.21 0.24
4 0.18 0.20
5 0.09 0.11
6 0.09 0.09
7 0.08 0.07
8 0.10 0.07
9 0.06 0.06
10 0.04 0.06
11 0.03 0.04
12 0.03 0.04
13 0.04 0.09
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Figure 3.3 Sucrose equilibrium gradient analysis of GLUT4 and IRAP in 3T3-L1 
adipocytes.
The peak GLUT4 containing fractions from the sucrose velocity gradient were pooled 
and subjected to sucrose equilibrium gradient analysis as described in the Methods 
section. 1ml fractions were pollected from the top of the gradient and 15pi of each 
fraction were separated by SDS-PAGE. The results shown are from a single gradient 
analysis, and are representative of three experiments. Typically fractions 5-10 were 
the GLUT4 containing fractions and were analysed further.
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Table 3.2 Protein profile of suerose equilibrium gradient fraetions
The peak GLUT4 containing fractions from the sucrose velocity gradient were pooled 
and subjected to sucrose equilibrium gradient analysis as described in the Methods 
section. 1ml fractions were eollected from the top of the gradient, and then each 
fraction assayed for its protein concentration. The results shown (on the table 
opposite) are from a single gradient analysis, and are representative of three 
experiments.
Note that unlike for the sucrose velocity gradient, here there is a significant difference 
between the protein concentration levels of the GLUT4 containing fractions. Fractions 
5-7 are seen to correspond to the insulin responsive GSV (see Figure 3.4), and here 
there is a significant reduction in protein concentration upon stimulation by insulin. 
Fractions 8-9 correspond to the recycling endosomal GLUT4, and here it is 
demonstrated that there is far smaller reduction in protein concentration upon 
stimulation by insulin.
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Table 3.2
Fraction No. Non-insulin stimulated cells 
(protein concentration mg/ml)
Insulin stimulated cells 
(protein concentration mg/ml)
1 0.01 0.01
2 0.01 0.01
3 0.02 0.02
4 0.02 0.03
5 0.12 0.05
6 0.18 0.12
7 0.15 0.12
8 0.11 0.08
9 0.03 0.04
10 0.03 0.03
11 0.02 0.02
12 0.01 0.02
13 0.03 0.04
î
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Figure 3.4 Analysis of peak GLUT4 containing fractions from the sucrose 
equilibrium gradient receptor.
The peak GLUT4 containing fractions from the sucrose equilibrium gradient were 
identified (fractions 5-10), and 15|xl of each fraction was then separated by SDS- 
PAGE in order to identify the resolution of the two intracellular GLUT4 
compartments. In order to do this, the basal and insulin-stimualated samples of each 
fraction were ran side-by side. Shown are typical immunoblots for the proteins 
indicated. Fractions 5-7 correspond to GLUT4 storage vesicles (GSVs) and 8-9 to the 
endosomal/TGN GLUT4 vesicles.
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Figure 3.5 Sucrose equilibrium gradient analysis of GLUT4, IRAP, VAMF2, 
TfR, ACRP30, Sec6 and Sec8 in 3T3-L1 adipocytes.
The peak GLUT4 containing fractions from the sucrose equilibrium gradient were 
identified (fractions 5-10), and 15pl of each fraction was then separated by SDS- 
PAGE. Having established which fractions correspond to GSVs and to endosomal 
GLUT4 it was possible to determine to what extent other trafficking proteins co- 
localise with the different GLUT4 pools. Shown are typical immunoblots for the 
proteins indicated, taken from 4 separate sucrose gradients.
[For IRAP, VAMP2, Sec6, Sec8 & TfR, the secondary antibody was HRP-conjugated 
donkey anti-mouse IgG, and for ACRP30 and GLUT4 the secondary antibody was 
HRP-conjugated donkey anti-rabbit IgG antibody]
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2. To express and purify this mutated protein and characterise its syntaxin-
binding properties compared to wild-type munc 18a and munc 18c.
3 To make a recombinant Adenovirus, of this mutated munc 18a, to drive
expression in mammalian cells.
4.2 Introduction
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CHAPTER 4 - PRODUCTION OF A MUTATED VERSION OF MUNC18A 
AND THE MUNC18-SYNTAXIN INTERACTION
4.1 Aims
1. To identify potential mutagenesis sites on munc 18a in order that its syntaxin- T|
binding properties are altered to become more like munc 18c.
if,
GLUT4 has been shown to translocate to the plasma membrane via a SNARE type 
mechanism (Cheatham et al 1996). VAMP2 has been identified as the v-SNARE 
responsible for GLUT4 translocation from GSVs, while cellubrevin is believed to be 
the v-SNARE involved in translocation of GLUT4 and (other proteins) from the 
endosomes to the plasma membrane (Martin et a l 1996; Martin et al 1998; Miller et
fal 1999). The corresponding t-SNAREs are syntaxin4 and SNAP23 (Rea et al 1998) 
and these are found mostly on the plasma membrane.
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The seel/munc 18 (SM) proteins are believed to modulate the interaction between 
vesicle and target membrane SNAREs, and thus regulate intracellular vesicular 
transport. The first SM protein to be identified was UNC-18 in genetic screen for f
uncoordinated phenotypes in C. elegans (Brenner 1974). The mammalian homologue, 
munc 18a, was identified by virtue of its ability to bind syntaxinl (Hata et al. 1993). It 
has since been discovered that all types of intracellular membrane traffic require an 
SM protein (for a review see Jahn et al. 1999).
Munc 18c is known to bind strongly to syntaxin4 (Tellam et al. 1997), an interaction 
that dramatically reduces the association of syntaxin4 and VAMP2 by 75%. Similarly 
munc 18c was also able to reduce the binding of cellubrevin to syntaxin4 by 60%
(Tellam et al. 1997). Co-immunoprecipation studies determined that syntaxin4 can
■ibind both SNAP23 and munc 18c in vivo, but that munc 18c decreases the affinity of 
syntaxin4 for SNAP23 (Araki et al. 1997). In the presence of insulin, it has been 
demonstrated that the munc 18c-syntaxin4 interaction has been lost (Thurmond et al.
1998). Taken together, the above would suggest an inhibitory role for munc 18c, 
preventing SNARE complex formation until the correct signal (the presence of 
insulin) is received.
In this chapter, we sought to mutate the neuronal munc 18a in such a manner to alter 
its syntaxin-binding characteristics to become more like those of munc 18c. Having | |
shown this to have been achieved it was then possible to make a recombinant |
Adenovirus of the mutated piunc 18a (in addition to wild-type munc 18a and munc 
18c) in order to drive expression in mammalian cells.
Glutamic Acid, Alanine, Arginine and Valine (IGEARV) starting at position 271; and 
a Glutamine at position 338 (Q).
4.3 Results
4.3.1 Production of muncl8a/c
3Potential sites of interaction between muncl8a and syntaxinl
B
3-The recent elucidation of the 3D structure of the munc 18a-syntaxinl interaction 
(Misura et al, 2000) allowed for potential points of contact to be identified between 
these proteins, based on close proximity of specific amino acids. From this, three
I
particular sites on munc 18a were identified as being potential points of contact. 
These were a Threonine at postion 52 (T52); a sequence of Isoleucine, Glycine,
I
A sequence alignment of munc 18a and munc 18c allowed identification of the 
corresponding amino acids on the munc 18c sequence (Figure 4.1). From the 
alignments, the three mutations we planned to introduce into munc 18a were the T52
. 'f,
to Glutamic Acid (T(52)J3); the IGEARV to Lysine and Glutamic Acid 
(IGEARV>KE); and Q338 to Arginine (Q(338)R) as highlighted.
Production of munclS a/c
Primers were designed for these three mutations (described above) in order to make a 
modified munc 18a, called munc 18a/c. The mutagenesis was carried out as described f
in the Methods section, and the sequence confirmed by automated sequencing before 
continuing with protein expression [Briefly the mutations were introduced by three
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sequential rounds of mutagenesis: in order IGEARV->KE, then T(52)E and finally 
Q(338)R] . Having confirmed the sequence, the mutated protein was expressed and 
purified (as in Methods) and this was confirmed by SDS-PAGE of the purified 
fractions. Figure 4.2 confirms the expression and purification of a munc 18a/c.
4.3.2 The munclS a/c mutations do not alter protein structure
In order to discover whether the three mutations carried out on munc 18a had any 
significant effect on the folding and overall structure of the protein, Circular
a
Dichroism Analyis (CD Analysis) was carried out.
Figure 4.3 shows the Far UV spectra for each of the three munc 18 proteins, which 
gives an indication of the secondary structure environment of a protein. As can be f
■;3
seen the spectra for all three are broadly the same (particularly for munc 18a and a/c).
This provides evidence that the secondary structure features present are very similar
after the mutations have been made.
■|■ i
I
Having shown no significant change caused to the secondary structure by the 
mutations, the Near UV spectra (Figure 4.4) allowed a comparison to be made 
between the tertiary structures of the three munc 18 proteins. As can be seen the 
spectra of munc 18a and a/c are again very similar, indicating that no significant 
alterations in the overall folding of the protein have been caused by the mutations.
The spectrum seen for munc 18c is quite different, particularly in the 260-280nm 
wavelength range. Readings in this range of the spectrum attribute to phenylalanine
4
115
 ^   _ _ _
(and possibly tyrosine) residues and as such it would suggest that the overall folding 
of munc 18c is different from both munc 18 and munc 18a/c.
However, the most important result to notice here is that we have confirmed that the 
three mutations introduced into munc 18a to produce munc 18 a/c have had no 
significant effect on the overall protein folding and shape.
4.3.3 Characterising the syntaxin interactions of munc 18a/c
It had been intended to investigate the binding capabilities of each munc 18-syntaxin 
interaction using a variety of methods. However, this proved to be problematic (and 
will be discussed below), and as such only the GST-pull down assay was able to 
produce positive results.
GST-pull down assay
As described in the Methods section, each munc 18 protein has a hisô-tag and each 
syntaxin is expressed as a GST-fusion protein. This allowed a GST-pull down assay 
to be used in order to determine the syntaxin-binding capabilities of the munc 18a/c 
protein, compared to the wild-type munc 18a and munc 18c.
Two other methods of investigating the binding capabilities of each munc 18-syntaxin 
interaction were attempted (using Ni^ '*‘-NTA agarose beads, and BIACORE 
techniques). These however proved to be problematic, but will be discussed below.
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As can be seen from Figure 4.5, as expected munc 18a is seen to interact with 
syntaxinl, and munc 18c does not. We have also been able to determine that the 
mutations introduced to munc 18a cause the loss of its interaction from syntaxinl 
(munc 18a/c does not interact with syntaxinl).
The pull-down assay using GST-syntaxin2 confirmed the interaction of both munc 
18a and munc 18c with syntaxin2. It was also seen that the munc 18a/c was able to 
interact with syntaxin2. From this data, the mutations have not altered the syntaxin2 
interaction.
The results seen in the pull-down assays with syntaxinS did not agree with previous 
findings. It had been previously established that whereas munc 18a binds to 
syntaxinS, munc 18c does not. However, our results suggested that munc 18c does 
interact with syntaxinS. As such it is difficult to determine anything from the finding 
here that munc 18a/c was seen not to interact with syntaxinS.
Crucially the syntaxin4 experiment established that munc 18a/c was able to bind to 
syntaxin4, like munc 18c is known to. The munc 18a protein was (as expected) unable 
to interact with syntaxin4, demonstrating that the tliree mutations introduced to 
munc 18a have altered its syntaxin4 binding capabilities, as was intended.
Therefore, from these GST-pull down assays it can be confirmed that the three 
mutations introduced into munc 18a have caused loss of binding to syntaxinl, and 
caused an interaction with syntaxin4 to be established.
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BIACORE techniques
Having now established the syntaxin-binding capabilities of each munc 18 protein, it 
had been hoped to use the BIACORE system in order to investigate the kinetics of 
each munc 18-syntaxin interaction. However as mentioned before this proved 
problematic.
In order to investigate the interaction, it was first necessary to amine-couple a GST 
antibody onto a standard BIACORE chip (Sensor Chip CM5). This was achieved 
using the EDC/NHS (N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide and N- «
hydroxysuccininiide) amine-coupling kit. Briefly, the EDC/NHS is passed over the 
flow cells on the CM5 chip, which activates the functional groups on the surface of 
the chip. That done, the GST antibody can undergo amine coupling to these activated 
surfaces, before finally any unreacted surfaces can be deactivated by ethanolamine 
[The above procedure was carried out following the instructions detailed in the 
Immobilization Wizard in BIACORE programmes].
:
Having successfully attached the GST antibody onto the chip, the aim was then to 
first flow a GST-syntaxin protein over the chip, and then compare the response seen 
when each munc 18 protein was injected into the system. However, as said before, we 
encountered problems at this stage. As a eontrol, one of the four flow cells on the chip 
is ‘blanked’ (no GST antibody attached) and as such the GST-syntaxin, and hence 
munc 18, proteins should not interact. This would mean that no response should be 
produced from this flow cell. However, despite repeating this experiment twice, each
Binding studies using Ni^^-NTA agarose beads
Here the hisg-tagged munc 18 protein is first incubated with Ni^^-NTA agarose beads, 
and then the syntaxin of interest is added. After an incubation period, the beads can be 
washed and then bound protein eluted by boiling in 1 x SDS buffer. This elutant can 
then be separated by SDS-PAGE, and the presence of syntaxin established by western 
blotting, using a GST antibody. As a control, Ni^^-NTA agarose beads were incubated
time a response was seen fi*om this blanked flow cell. This response was significant 
enough to cast doubt over the responses seen from the other activated flow cells.
As a result of this, we were unable to use this system as we had intended, in order to :
characterise the kinetics of the syntaxin-munc 18 interaction. It had been hoped to 
study the kinetics by a combination of altering the concentration of one of the 
substrates (with a constant flow rate), or by altering the flow rate of substrate through 
the cells (with constant substrate concentrations).
i
As an alternative to the GST-pull down assay, it should also have been possible to 
make use of N?^-NTA agarose beads (to interact with hisg-tagged munc 18 protein) in 
order to establish the binding interactions. However, this procedure too proved to be 
problematic.
•b;;
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■I'with syntaxin alone, which should not bind as the syntaxin proteins are GST-fused. b|
The results obtained however showed significant levels of GST-syntaxin in the 
control lanes, and because of this high background this method was shown to be 
unsuitable. 1
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Therefore, of the tliree potential mechanisms used in order to charcterise the synatxin- 
binding capabilities of each munc 18 protein, only the GST-pull down assay proved to 
have been successful. Using this method, it was possible to determine two key 
features of the syntaxin-binding behaviour of the munc 18a/c mutant. These are that 
munc 18a/c is unable to interact with syntaxinl (like the wild-type munc 18a), but is 
able to interact with syntaxin4 (like the wild-type munc 18c). I
4.3.4 Preparation for production of Adenoviral munc 18 proteins
As it had now been confirmed that munc 18a/c is able to bind to syntaxin4, the next 
aim was to over-express each munc 18 protein using the Adenoviral system.
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Initially, primers were designed in order to clone each of the munc 18 sequences into 
the pShuttle-CMV vector, and place a C-terminal FLAG tag onto the sequence 
(Figure 4.6A). The PCR reactions were carried out as described in the Methods 
section, and the product TAQ-treated and cloned into pCR2.1 (see Figure 4.6B). At 
this point the sequences were confirmed by automated sequencing before continuing 
with ligation with the pShuttle-CMV (see Figure 4.6B).
4.3.5 Munc 18 ligation with pShuttle-CMV
In order to ligate each munc 18 sequence into the shuttle vector, it was first necessary 
to digest each munc 18/pCR2.1 and pShuttle-CMV vector DNA with the appropriate 
restriction enzymes. Figure 4.7 shows a DNA gel of each of these digests. The bands 
corresponding to the digested munc 18 and pShuttle-CMV DNA were then gel 
purified in preparation for ligation.
î
;■’B:
:The ligation reaction was carried out as described in Methods section, and once
■:'k
transformed into TOP 10 cells and plated, colonies were selected. DNA from each of 
the colonies was then digested with the appropriate restriction enzymes in order to 
establish whether successful ligation has occurred. The results shown in Figure 4.8 
confirmed that each ligation had been successful, and the DNA from these ligations 
was used for future work.
4.3.6 BJ5183 co-transformation
Flaving successfully ligated each munc 18 gene into the pShuttle-CMV vector, the
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next step in the process of Adenovirus production was to co-transfbrm the linearised Itransfer vector (the munc 18/pShuttle-CMV vector digested with Pme I) and pAd- 
Easy vector into electrocompetent BJ5183 cells (see Figure 4.9). This was achieved
: |
by electroporation following the procedure in the Methods section. The '
transformation mix was then plated and the smallest colonies selected as possible 
recombinants [the larger colonies represent background from the shuttle vector]. DNA 
from each was then digested with Pac I  in order to verify whether the co­
transformation has been successful. Figure 4.10 is a DNA gel showing the successful
:recombinants for each of the three munc 18 genes, as well as the pAd-Easy control.
■I
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4.3.7 DH5a transformation
The BJ5183 cells, although suitable to allow recombination, are not stable and as such 
are prone to deletion. As a result, the pAd-Easy/Munc 18 plasmid is transformed into
successful. The results from Figure 4.11 demonstrate that the transformation has been 
achieved, and as such larger quantities of DNA, from successful digests, are produced 
prior to the HEK transfection.
4.3.8 Transfection of HEK cells with pAd-Easy/Muncl8 plasmid
1 2 2
"S
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more stable DH5a cells, which are suitable for producing large amounts of DNA
.(which is needed for transfecting cells). The transformation was achieved by 
electroporation, following the procedure in the Methods section. The transformation 
mix was then plated and a number of colonies selected. DNA from each was then 
digested with Pac I  in order to identify whether the transformation has been
.,3:■y;
At this stage it was then possible to attempt to transfect the PAd-Easy/Munc 18 
plasmid into HEK 293 cells. In order to do this, 20pg of each recombinant 
Adenovirus plasmid is first digested with Pac I. The transfection itself was carried out 
as described in the Methods section. After -10 days the cells were spun down, and 
cracked open to give the cell lysate (through a series of freeze-thaw cycles). If 
successful transfection, and consequent expression of the munc 18 constructs has 
occurred, then the presence of the protein can be identified by use of an antibody to 
the FLAG-tag. As can be seen in Figure 4.12, there has been successful transfection 
and expression for both munc 18a and munc 18a/c, but not for munc 18c. The 
transfection for munc 18c was repeated another twice, but this too was without 
success. It had been intended at this stage to continue by amplifying the production of
3 ,
each recombinant adenovirus, and purifying them. However time constraints plus the 
problems of achieving expression of the munc 18c adenovirus meant that this could 
not be done.
4.4 Discussion
GLUT4 has been shown to translocate to the plasma membrane via a SNARE type 
mechanism (Cheatham et al. 1996). The fusion of GSVs with the plasma membrane 
involves three helices from the t-SNAREs (two from SNAP23 and one from 
syntaxin4) and one helix from the v-SNARE (VAMP2). This SNARE mechanism 
(resulting in GLUT4 incorporation onto the plasma membrane) is strikingly similar to 
the mechanism by which neurotransmitter release occurs in the synapse.
It is known that all intiacellulai' membrane traffic requires a seel/munc 18 (SM) 
protein, as when no such protein is expressed there is a block in membrane fusion. 
These SM proteins are believed to modulate the interaction between vesicle and target 
membrane SNAREs, and thus regulate intracellular vesicular transport. Perhaps the 
best characterised isoform is the mammalian neuional munc 18a, which was identified 
by virtue of its ability to bind syntaxinl (Hata et al 1993).
The syntaxinl-munc 18a interaction is now knovm (Misura et al 2000) and this 
demonstrated that when munc 18a interacts with sytaxinl, it does so in such a way 
that the H3 domain (used in SNARE complex formation) comes into close proximity 
with three other N-terminal helices on syntaxinl (the Habc domain) and as such the
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and membrane fusion until required.
SNARE complex is not able to form. Syntaxinl is said to be in its “closed” 
conformation when bound to munc 18a.
Munc 18c is the homolgue found in insulin responsive tissues, although its less well 
understood than munc 18a. Munc 18c is known to bind strongly to syntaxin4 (Tellam 
et a l 1997), an interaction that dramatically reduces the formation of the SNARE 
complex. This interaction was deomonstrated to be lost upon insulin stimulation, 
implying that munc 18c has an inhibitory role in GLUT4 membrane fusion. Thus the 
actions of munc 18c and munc 18a seem to be quite similar: they both appear to bind
to their syntaxin-binding partner, and in doing so prevent SNARE complex formation
ii
It was thought originally that all SM proteins functioned by binding to closed 
conformations of syntaxins, and thus when bound to an SM protein the syntaxin was 
unable to form a SNARE complex. Recent discoveries have shown this not to be the 
case. For example the crystal structure of the SM protein Slyl showed considerable 
conservation, and had the same arch-shape, to that of Munc 18a. However unlike 
syntaxinl, here the syntaxin homologue (Sed5) does not bind the central cavity of its 
SM protein, but rather the outside of one of its three domains. As such Sed5 is able to 
bind its SM protein and form a SNARE complex simultaneously.
In this chapter, we sought to establish whether the neuronal munc 18a could be 
mutated in such a manner that its syntaxin-binding characteristics would become 
more like those of munc 18c. Three close points of contact between syntaxinl and 
munc 18a provided thi’ee possible sites of mutation that theoretically could alter the
Ï24
syntaxin-binding characteristics without causing any significant alteration to protein 
structure.
Figures 4.3 and 4.4 (the CD analysis) demonstiate that these three rounds of 
mutagenesis have not altered the protein structure greatly, since the spectra seen in 
both cases is very similar between munc 18a and the mutated form (muncl8a/c).
The binding studies seen in Figure 3.5 demonstrate that (as predicted) the mutated 
protein is no longer able to interact with syntaxinl, but is now able to interact with 
syntaxin4 like munc 18c does. It had been hoped to further characterise these 
interactions using the BIACORE system, but as detailed in Section 4.3.3 this proved 
to be problematic.
However, having shown the desired alteration in the syntaxin-binding behaviour of 
the mutated protein we were able to construct a recombinant Adenovirus of the 
mutated munc 18a (in addition to wild-type mime 18a and munc 18c) in order to drive 
expression in mammalian cells.
As seen in Figures 4.7-4.11, each munclS gene was successfully inserted into the 
pAd-Easy vector that is used to transfect HEK cells. However, upon transfection only 
the munc 18a and munc 18a/c were expressed in HEK cells. Even upon repetition of 
the transfection step for the pAd-Easy/Munc 18c expression could not take place.
At this stage, the study ended. It would have been difficult to progress from here since 
it had been hoped to ultimately overexpress each munc 18 adenoviral construct in 
3T3-L1 adipocytes and establish the effect on glucose transport. In this experiment
125
126
■te"
the results from an overexpressed munc 18c wild-type would have been an important 
reference point.
In conclusion then, here we identified three sites on munc 18a that theoretically could 3■'b
alter its syntaxin-binding behaviour: in particular cause the mutated protein to interact 
with the syntaxin involved in GLUT4 vesicle fusion (syntaxin4) and prevent 
interaction with the neuronal syntaxin (syntaxinl). We determined that this indeed 
was the case upon expression of munc 18a/c, and was without significant alteration to 
the protein structure. We also created recombinant Adenovirus constructs of each of 
the three munc 18 genes, although only two (munc 18a and munc 18a/c) were seen to 
be expressed in mammalian cells.
i;'
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Figure 4.1 Alignments of Munc 18a,b, c and une 18
The 3D structure of the munc 18a- syntaxinl interaction identified three close 
interactions (and hence possible points of contact) between the two proteins. The 
amino acids of munc 18a were noted, and then compared to the corresponding amino 
acids of munc 18c in a sequence alignment. From these alignments, three possible 
sites were identified for mutagenesis: T(52)E, an IGEARV to KE mutation starting at 
position 271, and Q(338)R.
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Figure 4.2 Purified hisg-tagged munc 18a/c.
Hisg-tagged munc 18a was mutated (as described in Methods), transformed into M l5 
ceils and protein expression induced with IPTG. The cell lysate was then passed 
through a 3 ml Ni^^-NTA agarose column, washed with Hisg-tag Purification Buffer 
(containing 50mM imidazole) and then 12 x 1ml fractions eluted from the column by 
applying a step gradient of increasing concentrations of imidazole in this buffer 
(ranging from 95mM-275mM). 20pl of each fraction was then separated by SDS- 
PAGE. The gel shows a band of -60 kDa which corresponds to hisg-tagged munc 18a.
129
Figure 4.2
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Figure 4.3 Far UV CD Analysis of munc 18a, a/c and c.
0.3mg/ml of each munc 18 protein were needed for Far UV CD Analysis. The figure 
shows the spectra for each of the three proteins [Munc 18a is pink, 18a/c is red and 
18c is blue]. It was first necessary to dialyse the purified proteins to remove imidazole 
from the samples (This figure is from an experiment done by Dr Sharon Kelly).
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Figure 4.4 Near UV CD Analysis of munc 18a, a/c and c.
1 .Omg/ml of each munc 18 protein were needed for Near UV CD Analysis. The figure 
shows the spectra for each of the three proteins [Munc 18a is pink, 18a/c is red and 
18c is blue]. Again, it was first necessary to dialyse the purified proteins in order to 
remove imidazole Ifom the samples (This figure is tfom an experiment done by Dr 
Sharon Kelly).
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Figure 4.5 Hise-tagged munc 18-syntaxin binding studies
Binding reactions were carried out as described (in Methods) and 20|al of each sample 
was separated by SDS-PAGE. Briefly 2p,M of GST or GST-synatxin protein were 
added to Glutathione beads, and incubated at 4°C with end-over-end rotation for Ih. 
An equivalent volume of hise-tagged munc 18 protein was then added to make a final 
concentration of IjaM for munc 18, and the mixture was incubated for 2h at 4°C with 
end-over-end rotation. The beads were then washed twice with Binding Buffer 
containing 1 mg/ml gelatin, and three times with Binding Buffer containing 5% 
glycerol. Any bound proteins were then eluted by boiling the beads in Sample Buffer. 
Shown are the immunoblots received for the his6-tag when interaction with each 
syntaxin is investigated [The secondary antibody used to recognise the His6-tag was 
HRP-conjugated donkey anti-mouse IgG].
The samples in each lane are:
1. his6-tagged munc 18a + GST-syntaxin
2. his6-tagged munc 18a + GST
3. his6-tagged munc 18 a/c + GST-syntaxin
4. his6-tagged munc 18a/c+ GST
5. hisô-tagged munc 18c + GST-syntaxin
6. his6-tagged munc 18c+ GST
7. his6-tagged munc 18a alone [0.05p,g of purified protein]
8. his6-tagged munc 18a/c alone [0.05pg of purified protein]
9. hise-tagged munc 18c alone [0.05|ag of purified protein]
10. GST-syntaxin alone [0.05 pg of purified protein]
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Figure 4.6A The munclS genes for production of recombinant Adenovirus
The figures opposite show simplified views of each of the three munc 18 constructs, 
showing how they have been modified in order to produce recombinant Adenoviral 
constructs of each. Restriction sites have been added to both the N and the C terminal 
end of each construct to allow successful ligation into the pShuttle-CMV vector, and a 
FLAG-tag at the C-terminus means that the expressed protein can be identified.
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Figure 4.6B Plasmid maps of pCR2.1 and pShuttle-CMV
After the completion of the PCR reactions to generate each of the constructs seen in 
Figure 4.6A, the PCR product is TA cloned into pCR2.1. The plasmid map of pCR2.1 
shows the multiple cloning site (MCS) into which the PCR product is cloned. 
Successful TA cloning will produce a plasmid of ~5.7kb in size.
[Note here the position of a Bgl II restriction site outwith the MCS (at position 1282) 
of pCR2.1, which is significant when the munc 18a and munc 18a/c/pCR2.1 plasmid is 
digested (see Figure 4.7)].
The pShuttle-CMV map shows the location of the MCS into which each munc 18 
construct is ligated. Note here that although the MCS of pShuttle-CMV does not 
contain a Bam HI restriction site (the munc 18c construct has been made with a BamHI 
site at its), a Bgl II digestion of pShuttle-CMV leaves the same overhang, allowing 
ligation to occur. Successful ligations will produce a plasmid of ~ 9.2kb in size.
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Figure 4.7 Samples for ligation of munc 18 into pShuttle-CMV vector.
Each of the three munc 18/PCR 2.1 constructs was digested with the desired 
restriction enzymes (as indicated) for ligation to occur (NB. pCR2.1 has an internal 
Bgl II site hence three bands are seen). Likewise the pShuttle vector was digested with 
the desired restriction enzymes, and a small sample of the digest was resolved by 
DNA gel electrophoresis. These samples were then gel purified prior to ligation.
1. Munc 18a/pCR2.1 digested with Bgl II & Hind III
2. Muncl 8a/c/pCR2.1 digested with Bgl II & Hind III [the smallest band here is 
very feint & its position is highlighted by an arrow on figure 4.7]
i. Munc 18c/pCR2.1 digested with Bam HI & Xho I
4. pShuttle-CMV digested with Bgl II & Hind III (for ligation with munc 18a and
a/c)
5. pShuttle-CMV digested with Bgl II  & Xho I  (for ligation with munc 18c)
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Figure 4.8 Results of ligation between munclSs and pShuttle-CMV
Ligation experiments were carried out as described (in Methods) and various colonies 
were selected. DNA from each was digested with the restriction enzymes indicated in 
order to establish whether successful ligation had occurred (NB. since there is no 
appropriate restriction site at the N-terminal end of the munc 18c sequence, Nde /  was 
used to digest the DNA: this has two sites in pShuttle-CMV and one internal site in 
munc 18c, hence a successful ligation would provide three bands upon digestion). A 
small sample of each digest was then resolved by DNA gel electrophoresis. The DNA 
from successful ligations (munc 18a lane 7, munc 18a/c lane 9 and munc 18c lane 8) 
was used in future work.
[The digested munc 18a and munc 18 a/c/pShuttle-CMV vectors give two bands of 
approximately 7.5 and 1.8 kb. The digested munc 18c/pShuttle-CMV vector gives 
tliree bands of approximately 4.6, 3.5 and 1.1 kb].
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Figure 4.9 Production of a recombinant pAd plasmid
The diagram opposite details how a recombinant Pad plasmid is generated from the 
linearised transfer vector (pShuttle-CMV/muncl8) and the p-Ad Easy vector. When 
the pShuttle-CMV/muncl8 is digested with Pme /  this produces linearised DNA with 
the “left arm” and “right arm” regions at either end. These "left arm" and "right arm" 
sequences represent the regions mediating homologous recombination between the 
shuttle vector and the adenoviral backbone vector.
In order to achieve the recombination, the transfer vector and pAd Easy vector are co­
transformed into BJ5183 cells by electroporation as described in Methods. Successful 
recombinants will be ~40kb in size, and will show resistance to Kanamycin.
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Figure 4.10 Results of co-transformation of pAd-Easy and munc 18s into BJ5183
electrocompetent cells
DNA from each successful ligation was first linearised using Pme I. This was then 
mixed with pAd-Easy and added to electrocompetent BJ5183 cells and electroporated 
(as described in Methods). DNA from colonies obtained was digested with Pac I  in 
order to discover if each munc 18 has been incorporated into the pAd-Easy. A small 
sample of each successful co-transformation was then resolved by DNA gel 
electrophoresis as shown [successful recombinants are -40 kb in size].
1. pAd-Easy digested with Pac I
2. pAd-Easy/Munc 18a digested with Pac I
3. pAd-Easy/Munc 18a/c digested with Pac I
4. pAd-Easy/Muncl 8c digested with Pac I
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Figure 4.11 Results of transformation of pAd-Easy/munc 18s into DH5a
electrocompetent cells
DNA from each successful co-transformation was added to electrocompetent DH5a 
cells and electroporated (as described in Methods). DNA from colonies obtained was 
digested with Pac I  in order to determine whether transformation has been successful. 
A small sample of each digestion was then resolved by DNA gel electrophoresis. The 
DNA from successful transformations (control lane 5, munc 18a lane 12, munc 18a/c 
lane 20 and munc 18c lane 24) was used in future work.
[DNA from the successful transformations again is ~40kb in size.]
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Figure 4.12 Transfection of munc 18s into HEK 293 cells
20|ug of each recombinant pAd-Easy/mime 18 plasmid was digested using Pac I  and 
transfected into HEK 293 cells (as described in Methods). 10 days after transfection, 
the cells were spun down (the supernatant gives a media (M) fraction) and 
resuspended in sterile PBS. This was then subjected to three freeze-thaw cycles, to 
break cells open, after which samples corresponding to cell membrane pellet (P) and 
cell lysates (L) were collected. A small aliquot of each was separated by SDS-PAGE. 
Shown is the immunoblot for the FLAG tag [munc 18 proteins are ~60kDa in size]. 
[The secondary antibody used to recognise the FLAG-tag was HRP-conjugated 
donkey anti-mouse IgG].
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CHAPTER 5-OVERVIEW
/IIn réponse to insulin, glucose is taken up by storage tissues such as muscle and fat, via 
a mechanism knovm to be mediated by the insulin responsive glucose transporter 
GLUT4. Under basal conditions, GLUT4 is sequestered intracellularly into two 
distinct intracellular locations. One of these is known to be endosomal in character, 
wheras the other represents the highly insulin responsive GLUT4 storage vesicles 
(GSVs). These GSYs are knovm to be retained intracellulaiy in the absence of insulin, 
but upon insulin stimulation they traffic rapidly to the plasma membrane to allow 
GLUT4 to fuse to the plasma membrane. It is this rapid translocation of these 
specialised GSYs that accounts for the large (up to ~20-fold) increase in GLUT4 
levels at the plasma membrane in response to insulin, compared to only a slight 
increase (~2-fold) in levels of recycling proteins such as the transferrin receptor.
It is only when present on the plasma membrane that GLUT4 is able to function and 
allow glucose transport. The fusion event with the plasma membrane occurs via a 
SNARE-type mechanism. The v-SNARE YAMP2 (which is present in GSYs) 
together with the t-SNAREs syntaxin4 and SNAP23 are responsible for the formation 
of a SNARE complex that is important for membrane fusion. The SM protein munc 
18c is known to interact with syntaxin4, which prevents the formation of the SNARE 
complex. This interaction is seen to be lost upon insulin stimulation. As such, munc 
18c could have an inhibitory role in GLUT4 translocation by preventing GLUT4 from 
fusing to the membrane in th^ absence of insulin.
A number of methods have been used in order to separate the two intracellular
GLUT4 pools. In Chapter 3 we confirmed the validity of a method involving a
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sucrose velocity gradient followed by a sucrose equilibrium gradient in 3T3-L1 
adipocytes (as described by Guilherme et al). This method demonstrates that the 
GSVs are indeed far more insulin sensitive than the endosomes. The results in 
Chapter 3 demonstrate that, in response to insulin stimulation, levels of both GLUT4 
and IRAP from fractions containing GSVs were reduced by -50%. This is in 
comparison to a more modest 10-20% decrease in levels of the same proteins from 
fractions corresponding to endosomal GLUT4 vesicles. In this chapter we also looked 
to see whether other proteins of interest co-localise with GSVs or endosomal GLUT4, 
and confirmed both that VAMP2 is found in GSVs, and that the transferrin receptor is 
native to an endosomal compartment.
In this chapter, we also demonstrated the presence of exocyst complex proteins (Sec6 
and Sec8) in GLUT4 containing fractions. Recently the exocyst complex has been 
identified as having a role in GLUT4 trafficking and fusion to the plasma membrane 
(Inoue et al 2003). Therefore the fact that we found these proteins in the same 
fractions as some of the GLUT4 vesicles suggests that there is some co-localisation 
between the exocyst complex and GLUT4, although it does not provide direct 
evidence of the exocyst complex being involved in GLUT4 translocation.
Results in Chapter 3 also suggest that there may be some co-localisation between 
ACRP30 and GLUT4. This finding is in conflict with previous results (Bogan & 
Lodish 1999). As such further analysis of this potential co-localisation would have to 
be carried out before any relevance can be placed on this result.
Using Stains-all dye a putative Ca^  ^ dependent kinase has been identified, although 
further investigation into this has not been able to be carried out. This finding could 
have been significant since Ca^  ^ has been shown to be involved in the insulin-
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of neurotransmitter release, where munc 18a holds syntaxin 1 in a “closed” 
conformation preventing membrane fusion until the desired time. In Chapter 4 we 
attempted to create a mutated version of this munc 18a (called munc 18a/c) with the
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stimulated transport of glucose in 3T3-L1 adipocytes (Whitehead et a l 2001) and as 
such any calcium-binding proteins found in GLUT4 containing vesicles would be of 
potential interest. Unfortunately as we were unable to obtain any cDNA or an 
antibody, this finding could not be explored further.
All membrane fusion events are known to involve SNARE proteins and an SM 
protein. The SM protein munc 18c is known to interact with syntaxin4 and hence 
interfere with the formation of a SNARE complex. By doing so the fusion of GSVs
with the plasma membrane is prevented, and as such munc 18c is believed to have an
-
inhibitory role in GLUT4 translocation. This mechanism is very similar to the method
■I
aim of identifying if it was possible to alter the syntaxin-binding characteristics of the
protein. Namely, we aimed to prevent this munc 18a/c fr om interacting with syntaxin 1 
(like wild-type munc 18a does) while at the same time allowing interaction with 
syntaxiii4 to occui' (like wild-type mime 18c). We demonstrated that the mutations 
introduced into munc 18a had no significant effect on the protein structure (by 
Circular Dichroism), and upon carrying out binding studies the predicted alterations in 
syntaxin binding were confirmed. Unfortunately we were unable to make use of
BIACORE techniques in order to study the kinetics of these munc 18- syntaxin |
i ; -
interactions in detail.
We also made Adenoviral constructs of munc 18a/c (in addition to wild-type munc 
18a and munc 18c) with the intention of driving the expression of these constructs in 
mammalian cells. A future aim would be to overexpress these in insulin responsive 
cells in order to identify the effect on glucose transport of the munc 18a/c protein in 
comparison to the wild-type munc 18c.
In conclusion, we have made use of the sucrose gradient technique in order to 
examine the intracellular distribution of GLUT4, and to identify proteins that may 
(based on there presence in the same fractions) co-localise with either GSVs or 
recycling endosomes. Further analysis would have to be carried out in order to 
confirm or rule out any co-localisation.
We have also been able to alter the syntaxin-binding characteristics of a munc 18 
protein, as we aimed to do. However we were unable to drive expression of all the 
Adenoviral constructs and as such we were unable to investigate any effects that the 
mutated munc 18a/c protein piay have on GLUT4 translocation at this time.
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